{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":199,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":199,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"4bfe58bd6a87","filters":{"venue":"Journal of Medical Economics"}},"results":[{"id":"W4200054040","doi":"10.1080/13696998.2021.2007691","title":"The Global South political economy of health financing and spending landscape – history and presence","year":2021,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":120,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"Science Fund of the Republic of Serbia; Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja","keywords":"Politics; Multinational corporation; Economic growth; East Asia; Development economics; Medicine; China; Business; Economics; Political science; Finance","authors":[{"name":"Mihajlo Jakovljević","is_ca":false},{"name":"Yansui Liu","is_ca":false},{"name":"Arcadio A. Cerda","is_ca":false},{"name":"Marta Simonyan","is_ca":false},{"name":"Tiago Correia","is_ca":false},{"name":"Richard M. Mariita","is_ca":false},{"name":"Ajantha Sisira Kumara","is_ca":false},{"name":"Leidy Y. García","is_ca":false},{"name":"K Krstić","is_ca":false},{"name":"Romanus Osabohien","is_ca":false},{"name":"Trần Khánh Toàn","is_ca":false},{"name":"Chiranjivi Adhikari","is_ca":false},{"name":"Nguyễn Thị Kim Chúc","is_ca":false},{"name":"Resham B. Khatri","is_ca":false},{"name":"Vijay Kumar Chattu","is_ca":true},{"name":"Liang WANG","is_ca":false},{"name":"Tissa Wijeratne","is_ca":false},{"name":"Eugène Kouassi","is_ca":false},{"name":"Habib Nawaz Khan","is_ca":false},{"name":"Mirjana Varjačić","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07373820326831175,"gpt":0.3464244995850857,"spread":0.2726862963167739,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002743994,0.0001467743,0.0002162428,0.0009854903,0.001054329,0.005160326,0.0002791484,0.0007173578,0.004267367],"category_scores_gemma":[0.002565901,0.0001724982,0.000227025,0.002070899,0.003794155,0.003024214,0.001999069,0.002267563,0.0003174628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003874903,"about_ca_system_score_gemma":0.006740132,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005904936,"about_ca_topic_score_gemma":0.00691308,"domain_scores_codex":[0.9986985,0.0006669177,0.00004986574,0.0001034035,0.0002336018,0.0002477372],"domain_scores_gemma":[0.9985722,0.0006078209,0.0002582995,0.00007338542,0.0002444877,0.0002436977],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000689936,0.00002645985,0.00990558,0.00120204,0.00008579811,0.0005862688,0.01114327,0.001249574,0.000766092,0.7307499,0.05343261,0.1907833],"study_design_scores_gemma":[0.00001498232,0.00003984197,0.02773155,0.001838814,0.00002881947,0.0005052667,0.008467045,0.000519263,0.0003801698,0.105861,0.8545763,0.0000368761],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.1099956,0.2512557,0.004023534,0.4632151,0.001968812,0.00003350617,0.0005301055,0.00005064065,0.1689269],"genre_scores_gemma":[0.8128793,0.1511392,0.001136858,0.02435933,0.001866051,0.0000419326,0.000241014,0.00007733177,0.008259027],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.005904936,"threshold_uncertainty_score":0.0281145,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2906443950","doi":"10.1080/13696998.2019.1590843","title":"The burden of osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and Argentina","year":2019,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":119,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Medicine; Latin Americans; Osteoporosis; Environmental health; Medical prescription; Indirect costs; Business","authors":[{"name":"Rima Aziziyeh","is_ca":true},{"name":"Mo Amin","is_ca":true},{"name":"Mohdhar Habib","is_ca":false},{"name":"J Garcia Perlaza","is_ca":false},{"name":"Kirk Szafranski","is_ca":false},{"name":"Rebecca K. McTavish","is_ca":false},{"name":"Tim Disher","is_ca":false},{"name":"Ana Lüdke","is_ca":false},{"name":"Chris Cameron","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04913371673496721,"gpt":0.3803805302742925,"spread":0.3312468135393253,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001093399,0.0004964129,0.000397396,0.001501319,0.0004209537,0.001212153,0.0003625436,0.0003458104,0.001749044],"category_scores_gemma":[0.002485152,0.0002406413,0.0008439067,0.001806963,0.0003117461,0.0005426164,0.0006627268,0.0003697991,0.0001005258],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003246648,"about_ca_system_score_gemma":0.002910328,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.2724484,"about_ca_topic_score_gemma":0.2145027,"domain_scores_codex":[0.9996178,0.0001592945,0.00003373019,0.00004993079,0.00008400415,0.00005523267],"domain_scores_gemma":[0.999252,0.0001913534,0.0002584812,0.00002206543,0.0002067781,0.00006930353],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004850414,0.0001257552,0.8740832,0.002642163,0.00139274,0.001520878,0.001249307,0.01304761,0.0006031293,0.008266131,0.01508964,0.08149435],"study_design_scores_gemma":[0.0003782855,0.0001747912,0.9098638,0.004322831,0.002100652,0.001714889,0.004605159,0.02025626,0.0003906241,0.003951712,0.05213754,0.0001034201],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"review","genre_scores_codex":[0.8533062,0.06976055,0.003909959,0.01461673,0.0001949099,0.0004382652,0.02539585,0.0001365951,0.0322409],"genre_scores_gemma":[0.9703545,0.02130587,0.002808179,0.0003276826,0.00004397888,0.0001822255,0.00414555,0.0000144176,0.0008175992],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.2724484,"threshold_uncertainty_score":0.541725,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2016112560","doi":"10.3111/13696998.2014.1003644","title":"Brain metastases in patients with ALK+ non-small cell lung cancer: clinical symptoms, treatment patterns and economic burden","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":101,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Crizotinib; Medicine; Lung cancer; Anaplastic lymphoma kinase; Internal medicine; Medical diagnosis; Oncology; ALK inhibitor; Brain metastasis; Ceritinib; Cancer; Metastasis; Radiology","authors":[{"name":"Annie Guérin","is_ca":true},{"name":"Medha Sasané","is_ca":false},{"name":"Jie Zhang","is_ca":false},{"name":"Kenneth W. Culver","is_ca":false},{"name":"Katherine Dea","is_ca":true},{"name":"Roy Nitulescu","is_ca":true},{"name":"Eric Q. Wu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01814210425179501,"gpt":0.3340671243455227,"spread":0.3159250200937276,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004494251,0.0001651083,0.0002787154,0.0008908538,0.0002518398,0.0005726595,0.00027139,0.0002422074,0.0009531756],"category_scores_gemma":[0.001681445,0.0001254731,0.0003551243,0.002093873,0.0001424553,0.0003677716,0.0003785453,0.0002481979,0.0001780065],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006553971,"about_ca_system_score_gemma":0.0004324243,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01261219,"about_ca_topic_score_gemma":0.01802328,"domain_scores_codex":[0.9994289,0.0001468835,0.0001195951,0.0001110798,0.0001228077,0.00007060889],"domain_scores_gemma":[0.9987078,0.00009238738,0.0009860322,0.00002987571,0.00009600035,0.0000879744],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00005009675,0.00001505832,0.9986228,0.00001091552,0.00003817137,0.00003676622,0.00001461981,0.00003366883,0.00004506608,0.000007788231,0.0001270891,0.0009978882],"study_design_scores_gemma":[0.000005816282,0.00003150424,0.9992187,0.000009475827,0.000014824,0.0002387769,0.0001114504,0.0001713847,0.00003319169,0.0000133875,0.0001493387,0.000001993031],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9971088,0.0006213828,0.00005713476,0.0001240209,0.000003606482,0.00001357016,0.001725311,0.000002335592,0.0003438481],"genre_scores_gemma":[0.9983605,0.0002569045,0.00006965386,0.00003000318,0.00000725607,0.00001162404,0.001205245,9.5186e-7,0.00005791565],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01261219,"threshold_uncertainty_score":0.02507758,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071344217","doi":"10.3111/13696998.2011.653726","title":"Satisfaction with botulinum toxin treatment: a cross-sectional survey of patients with cervical dystonia","year":2011,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Merz Pharmaceuticals","keywords":"Medicine; Cervical dystonia; Botulinum toxin; Patient satisfaction; Cross-sectional study; Quality of life (healthcare); Adverse effect; Physical therapy; Visual analogue scale; Internal medicine; Anesthesia; Surgery","authors":[{"name":"Kapil D. Sethi","is_ca":false},{"name":"Ramon L. Rodriguez","is_ca":false},{"name":"Babajide Olayinka","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03516939767736518,"gpt":0.2643901803924858,"spread":0.2292207827151206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001222569,0.00014146,0.000340179,0.0005875111,0.0003297177,0.0004911993,0.0002199425,0.0006252352,0.001724246],"category_scores_gemma":[0.00325034,0.0001961348,0.0004246639,0.0007965288,0.0002904731,0.0004917186,0.0003841813,0.000544178,0.0002294704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004122507,"about_ca_system_score_gemma":0.0003229592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005561303,"about_ca_topic_score_gemma":0.005632316,"domain_scores_codex":[0.9991635,0.0002892099,0.0001147313,0.000077411,0.0002404476,0.000114704],"domain_scores_gemma":[0.9975808,0.0005816758,0.001124811,0.00005056196,0.0002941572,0.0003679621],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004538714,0.00004829027,0.9981913,0.00001447137,0.00003374662,0.00003710256,0.0001708542,0.00003398066,0.00009108765,0.000005274501,0.0001188904,0.00120952],"study_design_scores_gemma":[0.000007257646,0.000269791,0.9986888,0.000007448713,0.00001290667,0.0002401038,0.0004533588,0.0001289705,0.00002412196,0.000003188725,0.0001603167,0.000003779475],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989994,0.000173832,0.00003893111,0.0001042093,0.000003427214,0.00001489421,0.0002734686,0.000002633667,0.0003891591],"genre_scores_gemma":[0.9995124,0.00008012211,0.00004389208,0.0000776762,0.000003352508,0.00001077664,0.0001787327,8.036807e-7,0.00009223108],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005561303,"threshold_uncertainty_score":0.01105785,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132266888","doi":"10.3111/13696998.2013.851082","title":"Prevalence and impact of constipation and bowel dysfunction induced by strong opioids: a cross-sectional survey of 520 patients with cancer pain: DYONISOS study","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Constipation; Cross-sectional study; Internal medicine; Cancer; Colorectal cancer; Physical therapy; Pathology","authors":[{"name":"Laurent Abramowitz","is_ca":false},{"name":"Nicolas Béziaud","is_ca":false},{"name":"L. Labrèze","is_ca":false},{"name":"V. Giardina","is_ca":false},{"name":"Sébastien Causse","is_ca":false},{"name":"B. Chuberre","is_ca":false},{"name":"François‐André Allaert","is_ca":false},{"name":"Serge Perrot","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02279694631245742,"gpt":0.2994614495204641,"spread":0.2766645032080066,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005929071,0.0002795716,0.0003553092,0.0006511277,0.0003930845,0.0005547305,0.0002344765,0.0005116828,0.001386169],"category_scores_gemma":[0.001089875,0.0003373403,0.0003929589,0.000623146,0.0002316793,0.0004240539,0.0004377246,0.0004233925,0.0004169792],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004678004,"about_ca_system_score_gemma":0.0003131155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01102772,"about_ca_topic_score_gemma":0.01358504,"domain_scores_codex":[0.9995052,0.0001759787,0.00005756948,0.00008982098,0.000088966,0.00008242736],"domain_scores_gemma":[0.9989492,0.0001572455,0.0004086861,0.00004398929,0.0001359863,0.0003048437],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00003805283,0.0000407209,0.999337,0.00000674572,0.00001983194,0.00003541408,0.00008194101,0.000009989599,0.0001081648,0.000002445002,0.0000483576,0.0002712135],"study_design_scores_gemma":[0.000009013042,0.000162233,0.9992436,0.000004027692,0.000009856442,0.0001473477,0.0002604186,0.00003769593,0.00001312929,0.000001379561,0.0001091411,0.000002152376],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993688,0.0001018737,0.00002266082,0.0000253271,0.000002295431,0.00001045756,0.0003286731,0.000001140561,0.0001387837],"genre_scores_gemma":[0.9991224,0.0001140372,0.00004816727,0.00005131057,0.000006030933,0.00001691504,0.0004928359,8.681575e-7,0.0001472997],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01102772,"threshold_uncertainty_score":0.02192706,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2264465777","doi":"10.3111/13696998.2016.1151432","title":"Economic evaluation of nivolumab for the treatment of second-line advanced squamous NSCLC in Canada: a comparison of modeling approaches to estimate and extrapolate survival outcomes","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"Bristol-Myers Squibb (Canada); McMaster University; McGill University; Golder Associates (Canada)","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Erlotinib; Nivolumab; Docetaxel; Quality-adjusted life year; Oncology; Lung cancer; Quality of life (healthcare); Cost effectiveness; Survival analysis; Internal medicine; Cancer; Immunotherapy; Epidermal growth factor receptor; Risk analysis (engineering)","authors":[{"name":"Ron Goeree","is_ca":true},{"name":"Julie Villeneuve","is_ca":true},{"name":"Jeff Goeree","is_ca":true},{"name":"John R. Penrod","is_ca":false},{"name":"Lucinda Orsini","is_ca":false},{"name":"Amir Abbas Tahami Monfared","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1385477431919973,"gpt":0.3627472802013817,"spread":0.2241995370093845,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008419349,0.001634641,0.001246101,0.002129469,0.001412665,0.002440109,0.002028522,0.001255299,0.001978139],"category_scores_gemma":[0.02298786,0.0006125555,0.002057052,0.002564629,0.0008228954,0.0009090287,0.001359297,0.00127425,0.00009608243],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08521019,"about_ca_system_score_gemma":0.04901507,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9158834,"about_ca_topic_score_gemma":0.8526226,"domain_scores_codex":[0.9962263,0.00240752,0.000154008,0.000182265,0.0006267389,0.0004032087],"domain_scores_gemma":[0.9895787,0.006691361,0.0007252249,0.0001892625,0.002264329,0.0005510311],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.004999693,0.0007720597,0.02581959,0.001312526,0.001184682,0.0002110047,0.0002672743,0.9152192,0.0003495405,0.008841014,0.002170571,0.03885299],"study_design_scores_gemma":[0.0009874158,0.001123567,0.01857713,0.0003639433,0.0007701238,0.00007986882,0.0004820534,0.9733353,0.0003258705,0.001941436,0.00191995,0.00009332296],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9496212,0.009273515,0.01415724,0.003646811,0.0001197273,0.002139579,0.004195577,0.000150634,0.01669572],"genre_scores_gemma":[0.9898366,0.002118268,0.005638544,0.0001990478,0.00001479263,0.000364641,0.0009445027,0.00002229264,0.0008612328],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08521019,"threshold_uncertainty_score":0.6182461,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2911474691","doi":"10.1080/13696998.2019.1582059","title":"CAR T-cells: costs, comparisons, and commentary","year":2019,"lang":"en","type":"letter","venue":"Journal of Medical Economics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"","keywords":"Medicine; Intensive care medicine; Actuarial science; Economics","authors":[{"name":"Annette E. Hay","is_ca":true},{"name":"Matthew C. Cheung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03332051064993916,"gpt":0.3124527859559872,"spread":0.279132275306048,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01826264,0.0007751255,0.001777961,0.001842443,0.003578653,0.005778805,0.003850755,0.05288355,0.01239577],"category_scores_gemma":[0.138107,0.0006858955,0.001460374,0.002630651,0.005735463,0.007007892,0.001990219,0.04121503,0.006453821],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01272453,"about_ca_system_score_gemma":0.01079539,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009271184,"about_ca_topic_score_gemma":0.008660207,"domain_scores_codex":[0.9839749,0.006541175,0.001729773,0.001557412,0.005107652,0.001089068],"domain_scores_gemma":[0.8875842,0.08945348,0.003361464,0.001401695,0.01411219,0.00408701],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001293087,0.00001941336,0.0002387712,0.00009932242,0.00001868776,0.0004990525,0.0001046821,0.0001089524,0.00005571616,0.0129351,0.9763257,0.009465295],"study_design_scores_gemma":[0.0002851999,0.0000853397,0.0009515508,0.001359106,0.00007532308,0.001568796,0.0008034807,0.0007478536,0.0003183174,0.06315657,0.9305331,0.0001153708],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.0001296392,0.001105024,0.00003002022,0.9919293,0.005711531,0.000002765823,0.00004093437,0.000003500632,0.001047337],"genre_scores_gemma":[0.005609235,0.001739778,0.0001402939,0.9484875,0.04199433,0.00002198469,0.00003239739,0.0000136409,0.001960841],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.05288355,"threshold_uncertainty_score":0.09658325,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2067254496","doi":"10.3111/13696998.2013.858634","title":"Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Rivaroxaban; Vitamin K antagonist; Pulmonary embolism; Low molecular weight heparin; Enoxaparin sodium; Deep vein; Cost effectiveness; Venous thrombosis; Thrombosis; Cost-effectiveness analysis; Anticoagulant; Anesthesia; Internal medicine; Warfarin; Atrial fibrillation","authors":[{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Craig I Coleman","is_ca":false},{"name":"Brahim Bookhart","is_ca":false},{"name":"Si-Tien Wang","is_ca":false},{"name":"Samir H. Mody","is_ca":false},{"name":"Kevin N. Tran","is_ca":false},{"name":"Daisy Y. Zhuo","is_ca":false},{"name":"Lynn Huynh","is_ca":false},{"name":"Edith A. Nutescu","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04347617111276509,"gpt":0.3114251669344934,"spread":0.2679489958217283,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003307378,0.0008340974,0.001885571,0.00118388,0.0003937942,0.00146456,0.001181496,0.001136313,0.00583021],"category_scores_gemma":[0.01018593,0.0007385038,0.003390465,0.0007678838,0.0005584068,0.001128285,0.0007265245,0.001160198,0.0001998221],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005194203,"about_ca_system_score_gemma":0.004462849,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01335794,"about_ca_topic_score_gemma":0.007633355,"domain_scores_codex":[0.9985056,0.000954043,0.00007344158,0.0001558376,0.0001287127,0.0001824357],"domain_scores_gemma":[0.9955445,0.003351841,0.0006236344,0.00006570652,0.0001379642,0.000276258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.007918819,0.0003599837,0.01192383,0.0004253674,0.001643355,0.0001971469,0.00004044604,0.9642618,0.0003515808,0.004636711,0.0007230789,0.007517814],"study_design_scores_gemma":[0.003105108,0.003328005,0.01100738,0.0004130608,0.003948839,0.0003555287,0.00008366072,0.9689002,0.00065832,0.006914304,0.001206961,0.00007863666],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9660412,0.00441131,0.01472938,0.001968761,0.0001301131,0.0006895558,0.003514389,0.00009309793,0.008422208],"genre_scores_gemma":[0.9962656,0.000636631,0.001541434,0.0001179827,0.00001332047,0.000177038,0.0006427192,0.000006546045,0.0005986717],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01335794,"threshold_uncertainty_score":0.03768677,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1971766459","doi":"10.3111/13696998.2014.925462","title":"Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians)","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Spasticity; Botulinum toxin; Stroke (engine); Cross-sectional study; Patient satisfaction; Physical therapy; Surgery","authors":[{"name":"Djamel Bensmaïl","is_ca":false},{"name":"Angelika Hanschmann","is_ca":false},{"name":"Jörg Wissel","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01372402664093165,"gpt":0.2616882392279374,"spread":0.2479642125870057,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004348747,0.000233338,0.0003917524,0.0007538465,0.0003422742,0.0006069006,0.0002298238,0.0006734957,0.00134238],"category_scores_gemma":[0.008597451,0.0002860921,0.0007365893,0.0009383444,0.0003973606,0.000596714,0.0006409134,0.0005276861,0.0002490814],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004942392,"about_ca_system_score_gemma":0.0004310394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002684466,"about_ca_topic_score_gemma":0.002967598,"domain_scores_codex":[0.9969516,0.001759438,0.0003677246,0.0001838682,0.0004556813,0.0002817766],"domain_scores_gemma":[0.9881055,0.004041661,0.004929864,0.0002716097,0.001625022,0.001026193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001506971,0.0001146658,0.9970036,0.00002260066,0.00006937442,0.0000287355,0.0005599415,0.00004853884,0.0001122648,0.000005505584,0.00007864639,0.001805443],"study_design_scores_gemma":[0.0000157026,0.0005801333,0.9983643,0.000006399833,0.00001729313,0.00008954776,0.0006229454,0.0001326549,0.00005813107,0.000003040838,0.0001046833,0.000005090037],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9993856,0.00006629642,0.00007509425,0.00003633492,0.000002120723,0.0000298936,0.0001971736,0.00000260193,0.0002048811],"genre_scores_gemma":[0.9993467,0.0000538285,0.00009401143,0.00006007764,0.000004213429,0.00004799743,0.0003016732,9.512015e-7,0.00009070925],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004348747,"threshold_uncertainty_score":0.02299863,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4311206227","doi":"10.1080/13696998.2022.2157596","title":"Socioeconomic burden of schizophrenia: a targeted literature review of types of costs and associated drivers across 10 countries","year":2022,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Socioeconomic status; Schizophrenia (object-oriented programming); Psychiatry; Demography; Environmental health; Gerontology; Population","authors":[{"name":"Anna Kotzeva","is_ca":false},{"name":"Deepali Mittal","is_ca":false},{"name":"Supriya Desai","is_ca":false},{"name":"Davneet Judge","is_ca":false},{"name":"Kunal Samanta","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02087375026887178,"gpt":0.3405422572108638,"spread":0.3196685069419921,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004610025,0.001344141,0.002851501,0.02588044,0.0006249144,0.002549294,0.0008142925,0.0009859862,0.002913605],"category_scores_gemma":[0.01400736,0.0006939787,0.005095354,0.02570711,0.0005166873,0.00204305,0.001490093,0.0006754449,0.0002555709],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004845669,"about_ca_system_score_gemma":0.007907856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01310349,"about_ca_topic_score_gemma":0.02194981,"domain_scores_codex":[0.9958177,0.001136308,0.001615582,0.000317327,0.0009038355,0.0002092141],"domain_scores_gemma":[0.9892876,0.006330256,0.002490394,0.0001129033,0.00163975,0.0001390618],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0003774486,0.00004964857,0.01494055,0.6248464,0.00935355,0.0008069518,0.0007688156,0.0008736558,0.0002928179,0.001851606,0.01028852,0.33555],"study_design_scores_gemma":[0.0001495004,0.0003665549,0.08996037,0.775921,0.0437061,0.002939139,0.003085505,0.0005516275,0.0004860584,0.001759486,0.08094173,0.0001329388],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005219036,0.9906121,0.0001639488,0.0009307468,0.0001062411,0.0001274374,0.001698569,0.000009056511,0.001132999],"genre_scores_gemma":[0.02248163,0.9758958,0.0004252068,0.0003240288,0.00006335937,0.00009986735,0.0006342415,0.000003822528,0.00007209981],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02588044,"threshold_uncertainty_score":0.03515792,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4220928355","doi":"10.1080/13696998.2022.2053403","title":"Total cost of testing for genomic alterations associated with next-generation sequencing versus polymerase chain reaction testing strategies among patients with metastatic non-small cell lung cancer","year":2022,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; KRAS; Internal medicine; Oncology; Personalized medicine; Polymerase chain reaction; Genetic testing; Cancer; Bioinformatics; Gene; Genetics; Colorectal cancer","authors":[{"name":"Julie Vanderpoel","is_ca":false},{"name":"Andrea L. Stevens","is_ca":false},{"name":"Bruno Émond","is_ca":true},{"name":"Marie‐Hélène Lafeuille","is_ca":true},{"name":"Annalise Hilts","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"Laura Morrison","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05704098488559464,"gpt":0.2991262615221178,"spread":0.2420852766365232,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002455038,0.0005427858,0.0006081107,0.000919704,0.0004388897,0.001530933,0.000830011,0.000929985,0.005306967],"category_scores_gemma":[0.008593046,0.0005262155,0.002046201,0.001466892,0.000399421,0.001405941,0.0007404711,0.0008387507,0.0002367395],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006641814,"about_ca_system_score_gemma":0.003224088,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03302751,"about_ca_topic_score_gemma":0.02390499,"domain_scores_codex":[0.9979833,0.00112418,0.0000974917,0.000194247,0.0002035604,0.000397267],"domain_scores_gemma":[0.9952867,0.003216723,0.0007781663,0.00006527597,0.0002177638,0.0004353634],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.001985432,0.0003477778,0.1664063,0.0001978267,0.0006435488,0.0007136624,0.0001159161,0.7994456,0.0004307434,0.004992107,0.002094627,0.02262649],"study_design_scores_gemma":[0.000381905,0.001752852,0.09068041,0.0002165828,0.001056538,0.001435078,0.0006577732,0.895146,0.0006054878,0.005757043,0.00224147,0.00006895053],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.979382,0.0008853599,0.007974607,0.002354589,0.00003620321,0.0002470115,0.003460509,0.00004301071,0.005616731],"genre_scores_gemma":[0.9962671,0.0003095719,0.001716671,0.0001523007,0.00001242826,0.00005429891,0.0008154229,0.000006027075,0.0006660971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03302751,"threshold_uncertainty_score":0.06567049,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3029092466","doi":"10.1080/13696998.2020.1776297","title":"Economic and humanistic burden associated with noncommunicable diseases among adults with depression and anxiety in the United States","year":2020,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Medical Expenditure Panel Survey; Depression (economics); Anxiety; Quality of life (healthcare); Obesity; Diabetes mellitus; Cohort; Health care; Internal medicine; Psychiatry","authors":[{"name":"Eric S. Armbrecht","is_ca":false},{"name":"Anuj Shah","is_ca":false},{"name":"Patricia Schepman","is_ca":false},{"name":"Ruchit Shah","is_ca":false},{"name":"Elizabeth Pappadopulos","is_ca":false},{"name":"Richard Chambers","is_ca":false},{"name":"Jennifer Stephens","is_ca":false},{"name":"Seema Haider","is_ca":false},{"name":"Roger S. McIntyre","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01152816784599526,"gpt":0.2746695736899241,"spread":0.2631414058439288,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005237235,0.0001088581,0.0001641188,0.0007436295,0.0003834977,0.00056191,0.0001669674,0.0002298545,0.002195814],"category_scores_gemma":[0.002867748,0.0001148763,0.0003634289,0.0008674192,0.0002405316,0.0003647884,0.000770679,0.0006050383,0.0001017715],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008008269,"about_ca_system_score_gemma":0.0006471398,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02669539,"about_ca_topic_score_gemma":0.06051709,"domain_scores_codex":[0.9993464,0.0002732333,0.00009470376,0.00003357205,0.0001457183,0.0001063877],"domain_scores_gemma":[0.9983377,0.000174146,0.0008863581,0.00004516532,0.0001770148,0.000379504],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00008546241,0.00008638707,0.9865112,0.00003675451,0.0001947318,0.000160452,0.00009913757,0.0002520641,0.00005457912,0.0003234614,0.002572976,0.009622692],"study_design_scores_gemma":[0.000008491817,0.00002080357,0.998247,0.00004696029,0.0000320179,0.0001223797,0.0002626313,0.0003731341,0.000009997249,0.0001565473,0.0007158715,0.000004210097],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98763,0.002170917,0.0001017592,0.003836059,0.00007136366,0.00002421101,0.001659437,0.000005158259,0.004501137],"genre_scores_gemma":[0.9977568,0.001031092,0.00008436285,0.0003242033,0.00006464242,0.000008068463,0.0004673629,9.887908e-7,0.0002625336],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02669539,"threshold_uncertainty_score":0.05308002,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2160861863","doi":"10.3111/13696998.2011.571328","title":"Impact of upper and lower gastrointestinal blood loss on healthcare utilization and costs: a systematic review","year":2011,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Anemia; Health care; Upper gastrointestinal bleeding; Blood loss; Gastrointestinal bleeding; Retrospective cohort study; Emergency medicine; Intensive care medicine; Medical record; MEDLINE; Disease; Blood transfusion; Systematic review; Surgery; Internal medicine; Endoscopy","authors":[{"name":"Donna R. Parker","is_ca":false},{"name":"Xuemei Luo","is_ca":false},{"name":"Jessica J. Jalbert","is_ca":false},{"name":"Annlouise R. Assaf","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06400063312899791,"gpt":0.3410981287151585,"spread":0.2770974955861606,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.00844318,0.001422098,0.007965348,0.01082257,0.0004882409,0.002784433,0.001608068,0.001693955,0.003599727],"category_scores_gemma":[0.05195865,0.00113934,0.009235987,0.01456478,0.0007548871,0.001873989,0.001126503,0.001121761,0.0002357882],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00355012,"about_ca_system_score_gemma":0.01000511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01195904,"about_ca_topic_score_gemma":0.02901481,"domain_scores_codex":[0.9892734,0.004018168,0.003636393,0.0006439678,0.002118987,0.0003091404],"domain_scores_gemma":[0.9489539,0.03674855,0.009663961,0.0004368385,0.0037832,0.0004135916],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0002194231,0.00001953542,0.003925308,0.9384922,0.0305301,0.0001434871,0.0001398752,0.000157761,0.00007248467,0.0001592796,0.001510713,0.0246298],"study_design_scores_gemma":[0.0003727156,0.0002448474,0.01977581,0.7864895,0.1796934,0.000782994,0.0003321292,0.0002435795,0.0001815814,0.0003367089,0.01148788,0.00005878086],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001966644,0.9967565,0.00008368879,0.0002404723,0.00007162864,0.0001250153,0.0005113776,0.000005270135,0.0002393809],"genre_scores_gemma":[0.04410665,0.9538268,0.0006091426,0.0004934535,0.0001003773,0.0004092057,0.0003524917,0.000006067839,0.00009585219],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9920347,"threshold_uncertainty_score":0.04465234,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141205234","doi":"10.3111/13696998.2013.846262","title":"Flexible insulin dosing improves health-related quality-of-life (HRQoL): a time trade-off survey","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Diabetes Management and Research","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Diabetes mellitus; Dosing; Basal (medicine); Population; Regimen; Type 2 diabetes; Basal insulin; Bolus (digestion); Quality of life (healthcare); Internal medicine; Endocrinology; Environmental health; Nursing","authors":[{"name":"Marc Evans","is_ca":false},{"name":"Henrik Holm Jensen","is_ca":false},{"name":"Mette Bøgelund","is_ca":false},{"name":"Jens Gundgaard","is_ca":false},{"name":"Barrie Chubb","is_ca":false},{"name":"Kamlesh Khunti","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06106726985167935,"gpt":0.3454085567362911,"spread":0.2843412868846117,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002664129,0.0002998475,0.0002505097,0.0005472387,0.0002373382,0.0005988346,0.0002148199,0.0003523508,0.001034906],"category_scores_gemma":[0.005074006,0.0001736103,0.001045896,0.001002328,0.0002565149,0.0005506295,0.0005207031,0.0004440094,0.000163652],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005179523,"about_ca_system_score_gemma":0.0001969764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004071563,"about_ca_topic_score_gemma":0.005668973,"domain_scores_codex":[0.9981516,0.001092245,0.0001607837,0.0001314692,0.0003151142,0.0001488527],"domain_scores_gemma":[0.9957466,0.0009854962,0.00236953,0.0002594696,0.0002674822,0.0003715724],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004010297,0.0001338248,0.9940057,0.00001828173,0.0002008408,0.00001797519,0.00008142096,0.0002327646,0.0001308241,0.00002119367,0.0001107744,0.004645447],"study_design_scores_gemma":[0.00001447496,0.0003993434,0.9985276,0.000008236186,0.00004590771,0.00005668003,0.0001148737,0.0005485868,0.00008168449,0.00002719758,0.0001693474,0.000005878911],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990733,0.0001129799,0.0001711355,0.0000277277,0.000003067984,0.0000127385,0.0002730669,0.000002546402,0.0003233881],"genre_scores_gemma":[0.9993437,0.00006324956,0.0001955437,0.00002306379,0.000004020159,0.000009591808,0.0002772155,9.918209e-7,0.00008262187],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004071563,"threshold_uncertainty_score":0.01408947,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050417509","doi":"10.3111/13696998.2013.841705","title":"Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Schizophrenia (object-oriented programming); Medicaid; Pediatrics; Internal medicine; Psychiatry; Health care","authors":[{"name":"Marie‐Hélène Lafeuille","is_ca":true},{"name":"Jonathan Gravel","is_ca":true},{"name":"Patrick Lefèbvre","is_ca":true},{"name":"John Fastenau","is_ca":false},{"name":"Erik Muser","is_ca":false},{"name":"Dilesh Doshi","is_ca":false},{"name":"Mei Sheng Duh","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01667223273340371,"gpt":0.2778757055518343,"spread":0.2612034728184305,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001067078,0.0003169166,0.0004606353,0.001632217,0.0002657358,0.0007492543,0.0003936347,0.0003370111,0.001089572],"category_scores_gemma":[0.005933794,0.0002192586,0.001039066,0.00181823,0.0001932653,0.0005774598,0.0008352689,0.0005058668,0.000134167],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001251974,"about_ca_system_score_gemma":0.0007061182,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01347709,"about_ca_topic_score_gemma":0.01646559,"domain_scores_codex":[0.9991291,0.0002633866,0.0001591905,0.0001218837,0.0002020981,0.0001243151],"domain_scores_gemma":[0.997378,0.0003525018,0.001750704,0.00008011573,0.0002594772,0.0001792698],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001729866,0.00002528371,0.9951869,0.00001643641,0.0001089943,0.00004167422,0.000049866,0.0005808378,0.00009604291,0.00004451582,0.0001349789,0.003541603],"study_design_scores_gemma":[0.00000983606,0.000075205,0.9944574,0.00002463624,0.00003550549,0.0002206683,0.0002132625,0.004708741,0.00004663363,0.00009033607,0.0001106852,0.000007021629],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989339,0.0002665698,0.0001167375,0.00009866575,0.000001551166,0.00001045595,0.0004077647,0.000005384797,0.0001589422],"genre_scores_gemma":[0.9991785,0.000103454,0.0001973193,0.00001408541,0.000002919819,0.000006885039,0.0004588056,0.00000201179,0.00003602071],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01347709,"threshold_uncertainty_score":0.02679729,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2166937404","doi":"10.3111/13696998.2010.499749","title":"The cost effectiveness of palivizumab: a systematic review of the evidence","year":2010,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Respiratory viral infections research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster Children's Hospital; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Cost effectiveness; Population; Pediatrics; MEDLINE; Cost-effectiveness analysis; Cost–utility analysis; Intensive care medicine; Environmental health; Risk analysis (engineering); Internal medicine; Respiratory system","authors":[{"name":"Kelly Smart","is_ca":true},{"name":"Krista L. Lanctôt","is_ca":true},{"name":"Bosco Paes","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1409699726642448,"gpt":0.4714586418945917,"spread":0.3304886692303469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01432809,0.002205093,0.01102177,0.01356681,0.0006126054,0.004182512,0.00237167,0.002692731,0.005903464],"category_scores_gemma":[0.06948308,0.001654653,0.01277559,0.01309311,0.0009300435,0.002642946,0.001528236,0.002051519,0.0003738309],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.009341356,"about_ca_system_score_gemma":0.01495656,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01208531,"about_ca_topic_score_gemma":0.02502689,"domain_scores_codex":[0.9864218,0.005404212,0.004304673,0.0007041705,0.002752636,0.0004125329],"domain_scores_gemma":[0.9404756,0.04494779,0.008901543,0.0005151731,0.00475688,0.0004030074],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004894914,0.00002362726,0.0008424991,0.9382557,0.01957622,0.0001195061,0.00006647031,0.0002929182,0.00008301249,0.0003348496,0.001691444,0.03822438],"study_design_scores_gemma":[0.0005706484,0.0002691191,0.004254023,0.8668084,0.1133117,0.0004710397,0.0001844539,0.0002609217,0.0001596507,0.0006176389,0.01305258,0.00003978299],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000775399,0.9978251,0.0001029328,0.0004034749,0.00009623088,0.0001848367,0.0003662976,0.000005356027,0.0002403828],"genre_scores_gemma":[0.01555482,0.9826278,0.0005193767,0.000494235,0.0001086136,0.0004188252,0.000193928,0.000007361657,0.00007508259],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01432809,"threshold_uncertainty_score":0.07577509,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2035214881","doi":"10.3111/13696998.2014.979938","title":"Cost-effectiveness analysis of neoadjuvant pertuzumab and trastuzumab therapy for locally advanced, inflammatory, or early HER2-positive breast cancer in Canada","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Ottawa; Ottawa Hospital; Roche (Canada)","funders":"","keywords":"Pertuzumab; Medicine; Trastuzumab; Oncology; Internal medicine; Breast cancer; Neoadjuvant therapy; Inflammatory breast cancer; Cancer","authors":[{"name":"C Attard","is_ca":false},{"name":"Amber N. Pepper","is_ca":false},{"name":"S. T. Brown","is_ca":false},{"name":"Melissa F Thompson","is_ca":false},{"name":"Per-Olof Thuresson","is_ca":false},{"name":"S. Yunger","is_ca":true},{"name":"Susan Dent","is_ca":true},{"name":"Alexander Paterson","is_ca":false},{"name":"George A. Wells","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02427292047140693,"gpt":0.3442561130701545,"spread":0.3199831925987475,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004155928,0.001092871,0.001178615,0.001701212,0.001012382,0.001961385,0.002028767,0.0009746068,0.002825452],"category_scores_gemma":[0.01323764,0.0007270274,0.002477387,0.002234849,0.0009440724,0.0006309836,0.001034319,0.0013156,0.0001082096],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.100622,"about_ca_system_score_gemma":0.0494932,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9509151,"about_ca_topic_score_gemma":0.9095958,"domain_scores_codex":[0.9972829,0.001168902,0.00008040766,0.0001896087,0.0004978426,0.0007803213],"domain_scores_gemma":[0.9941981,0.00342251,0.0005243761,0.0001320588,0.001190279,0.0005327296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.004366669,0.0005466454,0.04233965,0.0006261228,0.001404117,0.0004556935,0.0001475068,0.9215412,0.0005983169,0.008359242,0.003223311,0.01639146],"study_design_scores_gemma":[0.001197527,0.001136457,0.06506149,0.0001758052,0.001314576,0.0002091653,0.0005165678,0.9232833,0.0005937068,0.003103227,0.003275704,0.000132353],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9674584,0.003519513,0.004483263,0.002338854,0.00005097612,0.001238705,0.008675855,0.00008711115,0.0121474],"genre_scores_gemma":[0.9949675,0.0006137897,0.001471474,0.0001548717,0.000007687862,0.000150048,0.001514664,0.000009458181,0.00111058],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.100622,"threshold_uncertainty_score":0.7300669,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2128124805","doi":"10.3111/13696998.2013.770747","title":"Cost effectiveness of transcatheter aortic valve replacement compared to medical management in inoperable patients with severe aortic stenosis: Canadian analysis based on the PARTNER Trial Cohort B findings","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Vancouver General Hospital; University of British Columbia; Université Laval; Toronto General Hospital; University of Toronto","funders":"Edwards Lifesciences","keywords":"Medicine; Valve replacement; Stenosis; Emergency medicine; Cost effectiveness; Quality-adjusted life year; Cost-effectiveness analysis; Aortic valve replacement; Economic evaluation; Randomized controlled trial; Incremental cost-effectiveness ratio; Cohort; Cost–benefit analysis; Surgery; Internal medicine","authors":[{"name":"Rebecca Hancock","is_ca":false},{"name":"Christopher M. Feindel","is_ca":true},{"name":"Josep Rodés‐Cabau","is_ca":true},{"name":"John G. Webb","is_ca":true},{"name":"Ann Thompson","is_ca":false},{"name":"Kurt Banz","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01543467519830726,"gpt":0.295500422946994,"spread":0.2800657477486867,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007132837,0.001243574,0.002520262,0.001316118,0.0006019079,0.001966516,0.002121657,0.001050864,0.005661063],"category_scores_gemma":[0.01742043,0.000563883,0.01018313,0.002714185,0.000630039,0.0005267027,0.0009380807,0.00177711,0.000184799],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01474347,"about_ca_system_score_gemma":0.02040733,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8607382,"about_ca_topic_score_gemma":0.8310335,"domain_scores_codex":[0.9962422,0.001589239,0.0002862602,0.0005312897,0.0007581674,0.0005929086],"domain_scores_gemma":[0.9916453,0.003872375,0.001781328,0.0006281625,0.001364712,0.000708187],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2244018,0.001314581,0.3759049,0.01107354,0.08866031,0.0007814423,0.00044612,0.1713842,0.00133687,0.01174658,0.04913097,0.06381864],"study_design_scores_gemma":[0.1150437,0.007413875,0.5768151,0.002341354,0.08271377,0.000977006,0.0005889126,0.1924415,0.001147949,0.004476137,0.01525526,0.0007854583],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8755065,0.02131393,0.002645673,0.002582026,0.0001921854,0.001679821,0.0822235,0.0001249286,0.01373149],"genre_scores_gemma":[0.9736326,0.003530691,0.001750116,0.0005144565,0.00006753435,0.0003621638,0.01863334,0.00003940912,0.001469708],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9852566,"threshold_uncertainty_score":0.2801639,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1997932743","doi":"10.3111/13696998.2011.622323","title":"Health and economic impact of PHiD-CV in Canada and the UK: a Markov modelling exercise","year":2011,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"GlaxoSmithKline (Canada); McMaster University","funders":"","keywords":"Medicine; Haemophilus influenzae; Conjugate vaccine; Cohort; Pneumococcal conjugate vaccine; Epidemiology; Disease burden; Pandemic; Pneumonia; Herd immunity; Streptococcus pneumoniae; Intensive care medicine; Disease; Environmental health; Vaccination; Infectious disease (medical specialty); Immunology; Population; Coronavirus disease 2019 (COVID-19); Immunization; Internal medicine; Antibiotics","authors":[{"name":"Gerhart Knerer","is_ca":false},{"name":"Afisi Ismaila","is_ca":true},{"name":"David Pearce","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02227451260633569,"gpt":0.2648541504847154,"spread":0.2425796378783797,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00209695,0.0009969994,0.001205607,0.001263527,0.001844675,0.002446044,0.002191747,0.002096384,0.006126259],"category_scores_gemma":[0.006734634,0.000838001,0.001565078,0.001808714,0.001209007,0.0009407995,0.001349116,0.00179924,0.0004087482],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04282591,"about_ca_system_score_gemma":0.03173797,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9776863,"about_ca_topic_score_gemma":0.9547197,"domain_scores_codex":[0.9989134,0.0003471129,0.00003857542,0.0001250749,0.0001214439,0.0004543872],"domain_scores_gemma":[0.9960925,0.002418878,0.0002934174,0.00009909965,0.0007527347,0.000343439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0004894987,0.0001526452,0.02332986,0.0001376929,0.0001365736,0.0004224897,0.0002535895,0.9548415,0.0001510301,0.01193366,0.003741467,0.004410043],"study_design_scores_gemma":[0.0003178557,0.0001451344,0.01510911,0.0001339074,0.0001831314,0.00007357485,0.0006510592,0.9758099,0.00020169,0.002707859,0.004578523,0.00008839767],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9332884,0.001392572,0.01090606,0.003568475,0.00008292624,0.0005445331,0.01498172,0.0001250889,0.03511028],"genre_scores_gemma":[0.9812029,0.0009732555,0.003939163,0.0002009859,0.00001574296,0.0002299608,0.003536037,0.00002438925,0.009877541],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04282591,"threshold_uncertainty_score":0.3107252,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2141479869","doi":"10.3111/13696998.2013.852097","title":"Economic analysis of bevacizumab, cetuximab, and panitumumab with fluoropyrimidine-based chemotherapy in the first-line treatment of KRAS wild-type metastatic colorectal cancer (mCRC)","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Roche (Canada)","funders":"","keywords":"Cetuximab; Medicine; Panitumumab; Bevacizumab; KRAS; Colorectal cancer; Internal medicine; Oncology; Chemotherapy; Cancer","authors":[{"name":"Donna Lawrence","is_ca":false},{"name":"Michael Maschio","is_ca":false},{"name":"Kevin J. Leahy","is_ca":false},{"name":"S. Yunger","is_ca":true},{"name":"Jacob C. Easaw","is_ca":false},{"name":"Milton C. Weinstein","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02097388101552049,"gpt":0.2953600767874404,"spread":0.2743861957719199,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006629556,0.00127596,0.001896732,0.001576668,0.0005163656,0.002014205,0.001304961,0.001366075,0.004481004],"category_scores_gemma":[0.01617689,0.0009384956,0.003231388,0.001298952,0.0007156061,0.001227111,0.001156401,0.001795022,0.00018151],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.01610466,"about_ca_system_score_gemma":0.01084982,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.07419808,"about_ca_topic_score_gemma":0.04632517,"domain_scores_codex":[0.9977996,0.001464513,0.00005604978,0.0001271748,0.0002226711,0.000330003],"domain_scores_gemma":[0.9915206,0.006666448,0.0006190718,0.0001216292,0.0004535454,0.0006187657],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.004522868,0.0002950438,0.004722449,0.000608433,0.000802348,0.0001931841,0.00003240729,0.972711,0.0002605956,0.006200224,0.001237226,0.00841425],"study_design_scores_gemma":[0.001547776,0.001834233,0.006471664,0.0003580526,0.001779862,0.0001872443,0.0001086774,0.9803061,0.0004208085,0.004473399,0.002445353,0.00006668207],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9051465,0.01575386,0.02919481,0.00509757,0.0002471814,0.0025017,0.006067186,0.000120974,0.03587015],"genre_scores_gemma":[0.9908959,0.001537062,0.004010853,0.0002314423,0.00002890381,0.0003457952,0.0009361539,0.00001643467,0.001997322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07419808,"threshold_uncertainty_score":0.1475323,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1981297777","doi":"10.3111/13696990903442155","title":"The cost effectiveness of palivizumab in term Inuit infants in the Eastern Canadian Arctic","year":2009,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Respiratory viral infections research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Children's Hospital of Eastern Ontario; St. Joseph’s Healthcare Hamilton; McMaster Children's Hospital; St. Michael's Hospital; Sunnybrook Health Science Centre","funders":"Abbott Laboratories","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Cost effectiveness; Cost-effectiveness analysis; Emergency medicine; Respiratory system; Pregnancy; Internal medicine","authors":[{"name":"Derrick Y. Tam","is_ca":true},{"name":"Anna Banerji","is_ca":true},{"name":"Bosco Paes","is_ca":true},{"name":"Charles Hui","is_ca":true},{"name":"Jean‐Éric Tarride","is_ca":true},{"name":"Krista L. Lanctôt","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03774025749135262,"gpt":0.3618556405404861,"spread":0.3241153830491335,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002793218,0.0006925797,0.0006520296,0.000586724,0.0007193506,0.001624952,0.001409246,0.0005632223,0.001629061],"category_scores_gemma":[0.008415022,0.0002756197,0.001453431,0.0009293933,0.0004732652,0.000358545,0.0008013498,0.000671369,0.00006565087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.04134981,"about_ca_system_score_gemma":0.02187363,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9398653,"about_ca_topic_score_gemma":0.917488,"domain_scores_codex":[0.998584,0.0006189303,0.00005142976,0.000101043,0.0002959457,0.0003486108],"domain_scores_gemma":[0.9980108,0.001005369,0.000238439,0.00004268469,0.000414594,0.0002881715],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.02292959,0.0008891675,0.3776669,0.003836198,0.00712669,0.002374941,0.0009473492,0.4892461,0.003383023,0.008192825,0.008972107,0.07443514],"study_design_scores_gemma":[0.002171341,0.004282023,0.5367672,0.001881305,0.008227905,0.001587294,0.004224914,0.4249645,0.002988495,0.004340911,0.00827389,0.0002901721],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852751,0.005083613,0.0005755426,0.001035171,0.00003293451,0.0001308754,0.002531003,0.0000174642,0.005318298],"genre_scores_gemma":[0.9976317,0.0009805474,0.000360486,0.00008538282,0.000004773216,0.00003166567,0.0005446621,0.000004146508,0.0003566247],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06013471,"threshold_uncertainty_score":0.3000153,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2025655213","doi":"10.3111/13696998.2014.897628","title":"Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Purdue Pharma (Canada)","funders":"","keywords":"Medicine; Oxycodone; Medicaid; Medical prescription; Pharmacy; Opioid; Propensity score matching; Substance abuse; Medicare Part D; Opioid abuse; Emergency medicine; Observational study; Prescription drug; Psychiatry; Family medicine; Internal medicine; Health care; Pharmacology","authors":[{"name":"Louis F. Rossiter","is_ca":false},{"name":"Noam Y. Kirson","is_ca":false},{"name":"Amie Shei","is_ca":false},{"name":"Alan G. White","is_ca":false},{"name":"Howard G. Birnbaum","is_ca":false},{"name":"Rami Ben‐Joseph","is_ca":true},{"name":"Edward Michna","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00829051050439042,"gpt":0.258836376412609,"spread":0.2505458659082186,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008217765,0.0002527671,0.0001624369,0.0007026895,0.000186087,0.0006230432,0.0002935664,0.0003619205,0.0008377922],"category_scores_gemma":[0.003884915,0.0001460975,0.0008571543,0.000796577,0.0002547617,0.0005091951,0.0006144037,0.0004150824,0.00004512314],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003563755,"about_ca_system_score_gemma":0.001346483,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01810691,"about_ca_topic_score_gemma":0.02940695,"domain_scores_codex":[0.9991508,0.0003259733,0.00008554661,0.00008747102,0.0002460397,0.0001041416],"domain_scores_gemma":[0.9986552,0.0002808072,0.0007816717,0.00004123839,0.0001369634,0.0001041382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002102559,0.0007381169,0.8811727,0.0002659551,0.001051258,0.0003900386,0.000137943,0.01856723,0.001325166,0.001271905,0.001507612,0.09146957],"study_design_scores_gemma":[0.0001145979,0.001672372,0.9788963,0.0001009176,0.0005540326,0.0005318673,0.0003275049,0.01351442,0.001292383,0.0004546274,0.002515859,0.00002495586],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9967893,0.001075604,0.0003478141,0.0004173088,0.00001722291,0.00003595655,0.0005586353,0.000008305859,0.0007498718],"genre_scores_gemma":[0.9983618,0.0005237799,0.0004597448,0.0001435172,0.00001215088,0.00001643163,0.0003150645,0.000001327877,0.0001662056],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01810691,"threshold_uncertainty_score":0.03600305,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3130545975","doi":"10.3111/13696998.2013.784591","title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement","year":2013,"lang":"en","type":"editorial","venue":"Journal of Medical Economics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":37,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Ottawa Hospital; Institute of Health Economics; University of Ottawa","funders":"","keywords":"Checklist; Government (linguistics); Medicine; Statement (logic); Delphi method; Psychological intervention; Consolidated Standards of Reporting Trials; Systematic review; Economic evaluation; Delphi; MEDLINE; Public relations; Medical education; Political science; Psychology; Nursing; Law; Computer science","authors":[{"name":"Don Husereau","is_ca":true},{"name":"Michael Drummond","is_ca":false},{"name":"Stavros Petrou","is_ca":false},{"name":"Chris Carswell","is_ca":false},{"name":"David Moher","is_ca":true},{"name":"Dan Greenberg","is_ca":false},{"name":"Federico Augustovski","is_ca":false},{"name":"Andrew Briggs","is_ca":false},{"name":"Josephine Mauskopf","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.3160740589379751,"gpt":0.5300803307364624,"spread":0.2140062717984873,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.5288697,0.003363098,0.009426631,0.02362958,0.003399011,0.01692371,0.01012142,0.01271895,0.02454745],"category_scores_gemma":[0.7891197,0.004003167,0.01332513,0.0286739,0.006892712,0.0114924,0.008398188,0.02826476,0.01513036],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.012479,"about_ca_system_score_gemma":0.05891144,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006311517,"about_ca_topic_score_gemma":0.003768984,"domain_scores_codex":[0.3520709,0.3949468,0.1622311,0.00745109,0.07819878,0.00510125],"domain_scores_gemma":[0.1388697,0.472687,0.0796115,0.05821542,0.2460655,0.004550943],"domain_codex":"methods","domain_gemma":"reporting","domain_candidate":"reporting","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0009278897,0.0002170184,0.00204877,0.03793144,0.001177964,0.0001598844,0.001081433,0.002062751,0.0002743853,0.03659577,0.8145609,0.1029619],"study_design_scores_gemma":[0.00184005,0.000343698,0.007724201,0.07720659,0.001467397,0.000445248,0.0009780987,0.004694156,0.001348884,0.0675149,0.8359448,0.0004919684],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"methods","genre_gemma":"methods","genre_scores_codex":[0.004170225,0.03182135,0.3444197,0.2022407,0.04074129,0.1621873,0.1395198,0.01107417,0.06382544],"genre_scores_gemma":[0.02661745,0.02469546,0.4680295,0.03316002,0.006548612,0.3364825,0.09132899,0.002937583,0.01019997],"genre_candidate":"methods","genre_consensus":"methods","teacher_disagreement_score":0.4711303,"threshold_uncertainty_score":0.5809876,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3155883542","doi":"10.1080/13696998.2021.1917140","title":"Cost-effectiveness of pembrolizumab compared with chemotherapy in the US for women with previously treated deficient mismatch repair or high microsatellite instability unresectable or metastatic endometrial cancer","year":2021,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Pembrolizumab; Endometrial cancer; Microsatellite instability; Oncology; Internal medicine; Chemotherapy; Cost effectiveness; Cancer; Quality of life (healthcare); Clinical trial; Immunotherapy","authors":[{"name":"Elizabeth Thurgar","is_ca":false},{"name":"Mark Gouldson","is_ca":false},{"name":"Suzette M. Matthijsse","is_ca":false},{"name":"Mayur M. Amonkar","is_ca":false},{"name":"Patricia Marinello","is_ca":false},{"name":"Navneet Upadhyay","is_ca":false},{"name":"Chizoba Nwankwo","is_ca":false},{"name":"Raquel Aguiar‐Ibáñez","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0601413884066394,"gpt":0.3432891180794398,"spread":0.2831477296728004,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005333854,0.0007960078,0.001366165,0.0008064374,0.0002304265,0.001324974,0.0008581865,0.001174552,0.003866452],"category_scores_gemma":[0.01991933,0.0005305971,0.003456247,0.0008346197,0.0004241879,0.00111109,0.0008507533,0.001342101,0.0001315651],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005641978,"about_ca_system_score_gemma":0.002384053,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01862414,"about_ca_topic_score_gemma":0.01265347,"domain_scores_codex":[0.9973948,0.001965804,0.00009713638,0.000205939,0.0001505227,0.0001857523],"domain_scores_gemma":[0.9945852,0.004185748,0.0007542219,0.0001216464,0.0001608316,0.0001924159],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.06271152,0.001497882,0.03931938,0.002045914,0.009195453,0.0004071484,0.0001418721,0.8112291,0.001011382,0.008765877,0.003713882,0.05996063],"study_design_scores_gemma":[0.01522584,0.02337439,0.06834383,0.001800424,0.01645953,0.0008173933,0.0005380907,0.8491526,0.001913478,0.01506124,0.007127182,0.0001859897],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9735771,0.01099098,0.004082646,0.00247631,0.0001091255,0.000535284,0.003589023,0.0000639258,0.004575627],"genre_scores_gemma":[0.9967244,0.001196814,0.0006962887,0.0002355089,0.00001388965,0.0001517523,0.0006063971,0.000006501721,0.0003683665],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01862414,"threshold_uncertainty_score":0.04093564,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4223492032","doi":"10.1080/13696998.2022.2063603","title":"Carbon footprint and associated costs of asthma exacerbation care among UK adults","year":2022,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Climate Change and Health Impacts","field":"Environmental Science","cited_by":36,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Carbon footprint; Exacerbation; Greenhouse gas; Asthma; Medicine; Asthma exacerbations; Environmental health; Population; Internal medicine","authors":[{"name":"Kalé Kponee-Shovein","is_ca":false},{"name":"Jessica Marvel","is_ca":false},{"name":"Ryotaro Ishikawa","is_ca":false},{"name":"Abhay Choubey","is_ca":false},{"name":"Harneet Kaur","is_ca":false},{"name":"Praveen Thokala","is_ca":true},{"name":"Khadidja Ngom","is_ca":false},{"name":"Iman Fakih","is_ca":false},{"name":"Todd Schatzki","is_ca":false},{"name":"James Signorovitch","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01600650891459382,"gpt":0.2557213518250877,"spread":0.2397148429104939,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006048757,0.0003396761,0.0002748501,0.001440751,0.000191545,0.001063572,0.0002946651,0.0005778656,0.004071916],"category_scores_gemma":[0.004476016,0.0001874337,0.0009547448,0.002531456,0.000251412,0.0009087087,0.0009256454,0.0004722065,0.0003764907],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002409088,"about_ca_system_score_gemma":0.001120706,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.07807621,"about_ca_topic_score_gemma":0.06350673,"domain_scores_codex":[0.9987938,0.000312303,0.0002081645,0.0001234268,0.0003842477,0.0001780101],"domain_scores_gemma":[0.9976968,0.0003973196,0.001198633,0.00006255571,0.0004937622,0.0001508926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002672735,0.00005449315,0.9084987,0.002355824,0.0006992693,0.0008528887,0.0005583441,0.01451338,0.0006282759,0.003083847,0.01266118,0.05582656],"study_design_scores_gemma":[0.0000350869,0.0001620906,0.970087,0.001379828,0.0002654579,0.001104893,0.0007989506,0.006981309,0.0003142227,0.001282293,0.01754544,0.00004340102],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9071156,0.01929753,0.00238929,0.004379147,0.0001392548,0.0002389498,0.04862522,0.00007051873,0.01774441],"genre_scores_gemma":[0.9859848,0.005620973,0.0009670804,0.0002809527,0.00005965978,0.0001002394,0.005988732,0.000008232002,0.0009891808],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07807621,"threshold_uncertainty_score":0.1552435,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2090977676","doi":"10.3111/13696998.2015.1025793","title":"Utilities for asthma and COPD according to category of severity: a comprehensive literature review","year":2015,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; COPD; Asthma; Pulmonary disease; Quality of life (healthcare); MEDLINE; Internal medicine; Severity of illness; Physical therapy; Disease; Intensive care medicine","authors":[{"name":"Thomas R. Einarson","is_ca":true},{"name":"Basil G. Bereza","is_ca":true},{"name":"T. Anders Nielsen","is_ca":false},{"name":"M. Hemels","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07019135828087612,"gpt":0.3909560922612119,"spread":0.3207647339803357,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006526122,0.00137965,0.005463209,0.02350596,0.0005066866,0.002478526,0.001361788,0.001378194,0.002968824],"category_scores_gemma":[0.03259316,0.0008113057,0.008042708,0.02131786,0.0006149535,0.002557599,0.001163178,0.0009761825,0.0002005866],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004020914,"about_ca_system_score_gemma":0.004606488,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005958416,"about_ca_topic_score_gemma":0.009558139,"domain_scores_codex":[0.9948631,0.001573054,0.001971376,0.0003891203,0.00102161,0.0001817901],"domain_scores_gemma":[0.9747334,0.02006598,0.003468737,0.0001703972,0.001379939,0.0001816081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004594893,0.00007204044,0.01039368,0.6992782,0.01091905,0.0002859011,0.0004859674,0.0006838906,0.0001247321,0.00110999,0.005126656,0.2710605],"study_design_scores_gemma":[0.0002987619,0.000462029,0.05647365,0.8412522,0.05951729,0.002753794,0.001432274,0.0008254998,0.0002087423,0.002440924,0.03418843,0.0001463626],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002028879,0.9968848,0.0001164219,0.0002694213,0.00004184681,0.00006310014,0.0003372034,0.000004118669,0.0002541675],"genre_scores_gemma":[0.02496438,0.9734237,0.0007112572,0.0002655246,0.0000749877,0.0001698696,0.0003341349,0.000003416964,0.00005269577],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02350596,"threshold_uncertainty_score":0.03451389,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2290821530","doi":"10.3111/13696998.2016.1151431","title":"A global economic model to assess the cost-effectiveness of new treatments for advanced breast cancer in Canada","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":34,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Lapatinib; Letrozole; Anastrozole; Breast cancer; Quality-adjusted life year; Context (archaeology); Cost effectiveness; Metastatic breast cancer; Oncology; Internal medicine; Pharmacoeconomics; Economic evaluation; Quality of life (healthcare); Tamoxifen; Cancer; Trastuzumab; Intensive care medicine","authors":[{"name":"C. Beauchemin","is_ca":true},{"name":"Nathalie Letarte","is_ca":true},{"name":"K. Mathurin","is_ca":true},{"name":"Louise Yelle","is_ca":true},{"name":"Jean Lachaîne","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05054085207464628,"gpt":0.3117716208106228,"spread":0.2612307687359765,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001659308,0.001472518,0.001026407,0.001624439,0.0008892314,0.002131248,0.002166619,0.001734427,0.008262313],"category_scores_gemma":[0.006063542,0.0006879324,0.001261832,0.002534876,0.0009874997,0.001042328,0.00106099,0.001524037,0.000415456],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02176585,"about_ca_system_score_gemma":0.01882021,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7329158,"about_ca_topic_score_gemma":0.5827721,"domain_scores_codex":[0.999276,0.0003066682,0.00002240736,0.00009922911,0.0001105067,0.0001851829],"domain_scores_gemma":[0.9983359,0.0009516779,0.00009402227,0.00003584578,0.0004510186,0.0001315934],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.00006842272,0.00001320975,0.001021982,0.00003297291,0.00003125476,0.00006356471,0.00001571011,0.9849059,0.00003385032,0.0101446,0.001477411,0.002191141],"study_design_scores_gemma":[0.00009043939,0.00003117494,0.0008543086,0.00002297057,0.00004134544,0.00003543127,0.00004583254,0.9906791,0.00003289766,0.005341459,0.00281001,0.00001506286],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4660456,0.005830138,0.2618045,0.01260756,0.0005187965,0.002409534,0.03838994,0.0007812122,0.2116127],"genre_scores_gemma":[0.9338687,0.002011815,0.03339918,0.000514572,0.00005907927,0.0007489824,0.004842634,0.00008888738,0.0244662],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9782342,"threshold_uncertainty_score":0.5373142,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2072574820","doi":"10.3111/13696998.2013.772058","title":"Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"GlaxoSmithKline","keywords":"Medicine; Lupus nephritis; Systemic lupus erythematosus; Population; Internal medicine; Health care; Lupus erythematosus; Disease; Immunology","authors":[{"name":"Daniel E. Furst","is_ca":false},{"name":"Ann E. Clarke","is_ca":true},{"name":"Ancilla W. Fernandes","is_ca":false},{"name":"Tim Bancroft","is_ca":false},{"name":"Kavita Gajria","is_ca":false},{"name":"Warren Greth","is_ca":false},{"name":"Şerban R. Iorga","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01406123559023009,"gpt":0.2704657022021613,"spread":0.2564044666119312,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004584792,0.0002434333,0.0003341814,0.0008562005,0.0004961059,0.0007005411,0.0003297479,0.0004629401,0.001275289],"category_scores_gemma":[0.002142784,0.0002355806,0.0005032188,0.001241977,0.0002533655,0.0005237924,0.0004642469,0.0005827412,0.0001498953],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006813029,"about_ca_system_score_gemma":0.0003621652,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01358016,"about_ca_topic_score_gemma":0.01096154,"domain_scores_codex":[0.9994956,0.0001441855,0.00006624684,0.00008538431,0.0001251956,0.00008329955],"domain_scores_gemma":[0.9990006,0.0001427603,0.0005634545,0.00003423248,0.00005602613,0.0002030279],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006470178,0.0000623404,0.9991092,0.000003518192,0.00006029258,0.00009134755,0.00003207959,0.00005042964,0.00004545319,0.0000101615,0.00006574293,0.0004047914],"study_design_scores_gemma":[0.000008639161,0.00006935187,0.9992435,0.000003036193,0.0000189732,0.0002249215,0.00009283094,0.0002729773,0.00001073546,0.00001133899,0.00004147636,0.000002260955],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9994799,0.0001025925,0.0000128597,0.00004190065,0.00000210694,0.000004111614,0.0002049204,0.000001174127,0.0001503769],"genre_scores_gemma":[0.9995573,0.00005167442,0.00002581749,0.00002797634,0.000009033755,0.000005134111,0.0002760366,4.20567e-7,0.00004661628],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01358016,"threshold_uncertainty_score":0.02700222,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107285363","doi":"10.3111/13696998.2014.923892","title":"A Canadian cost-effectiveness analysis of transcatheter mitral valve repair with the MitraClip system in high surgical risk patients with significant mitral regurgitation","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"MitraClip; Medicine; Mitral regurgitation; Quality-adjusted life year; Mitral valve; Mitral valve repair; Quality of life (healthcare); Heart failure; Cost–utility analysis; Cardiology; Surgery; Cost effectiveness; Intensive care medicine; Internal medicine; Risk analysis (engineering)","authors":[{"name":"Heather Cameron","is_ca":false},{"name":"Lisa Bernard","is_ca":false},{"name":"Vincent Garmo","is_ca":false},{"name":"John Hernandez","is_ca":false},{"name":"Anita Asgar","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.005844515260005902,"gpt":0.253686271921591,"spread":0.2478417566615851,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004306099,0.001618208,0.001677694,0.002028457,0.0009407076,0.00174114,0.002011545,0.001219968,0.003260507],"category_scores_gemma":[0.01356153,0.0007421435,0.004697231,0.002823358,0.0006286291,0.0006082504,0.000856238,0.001413998,0.000141312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05938112,"about_ca_system_score_gemma":0.04418763,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9192695,"about_ca_topic_score_gemma":0.8670254,"domain_scores_codex":[0.997267,0.001250257,0.00009697751,0.0002130513,0.0007158278,0.0004569547],"domain_scores_gemma":[0.9964372,0.001740764,0.0003655959,0.00009961386,0.001032623,0.0003241756],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.01138716,0.0008399536,0.03832326,0.003536945,0.007908685,0.0007338334,0.0001503559,0.8787249,0.001249085,0.0106901,0.009464861,0.03699089],"study_design_scores_gemma":[0.009739458,0.003494541,0.1114056,0.001179842,0.01064268,0.0005798522,0.0003939593,0.845037,0.0008805115,0.003779015,0.01244891,0.0004185993],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8988603,0.02281668,0.009364971,0.00624418,0.0002543339,0.002827159,0.02913457,0.0001539953,0.03034377],"genre_scores_gemma":[0.987899,0.002544737,0.003825168,0.0003509601,0.00002621881,0.0002679176,0.003711973,0.00001370321,0.001360251],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0807305,"threshold_uncertainty_score":0.4308422,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1968579243","doi":"10.3111/13696998.2014.909436","title":"Inflammatory bowel disease: healthcare costs for patients who are adherent or non-adherent with infliximab therapy","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; Robarts Clinical Trials","funders":"Janssen Scientific Affairs","keywords":"Medicine; Infliximab; Inflammatory bowel disease; Disease; Health care; Internal medicine; Intensive care medicine","authors":[{"name":"George J. Wan","is_ca":false},{"name":"Chris M Kozma","is_ca":false},{"name":"Terra Slaton","is_ca":false},{"name":"William H. Olson","is_ca":false},{"name":"Brian G. Feagan","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008427640331969043,"gpt":0.251802811231127,"spread":0.243375170899158,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007144337,0.0002064589,0.0003931706,0.0005379979,0.000308951,0.0006799463,0.0002390551,0.0004262842,0.001937611],"category_scores_gemma":[0.003777834,0.000135512,0.0006452888,0.001194649,0.0001834491,0.0005137763,0.0006720322,0.0007668355,0.0001510284],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004466186,"about_ca_system_score_gemma":0.0004503883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004611148,"about_ca_topic_score_gemma":0.007774542,"domain_scores_codex":[0.9991353,0.0002904236,0.0001350366,0.00009649839,0.0002363869,0.00010634],"domain_scores_gemma":[0.9972177,0.0003357136,0.002050549,0.00006545427,0.0001122604,0.0002184245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00023438,0.0001259177,0.9846904,0.0001056569,0.0003323485,0.0001012346,0.00004955972,0.0004219339,0.00009438855,0.0002039184,0.0006707521,0.01296951],"study_design_scores_gemma":[0.00003060163,0.0001423664,0.9972663,0.00008138191,0.0001171633,0.0004022288,0.0001025349,0.0009244003,0.00003658126,0.000169424,0.0007221668,0.000004874893],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9925762,0.002656436,0.0002412069,0.0009589166,0.00001970884,0.00003052331,0.001803215,0.000006784895,0.001706953],"genre_scores_gemma":[0.9977197,0.000636736,0.0002268369,0.0001672329,0.00003640251,0.00001666733,0.0009549714,0.000001359574,0.0002400917],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004611148,"threshold_uncertainty_score":0.009168565,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2130922075","doi":"10.3111/13696998.2012.737393","title":"Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada","year":2012,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; McMaster University; St. Joseph’s Healthcare Hamilton; Amgen (Canada)","funders":"","keywords":"Medicine; Denosumab; Discontinuation; Osteoporosis; Femoral neck; Cost effectiveness; Internal medicine; Teriparatide; Cost-effectiveness analysis; Cohort; Adverse effect; Bone mineral","authors":[{"name":"Diane Chau","is_ca":true},{"name":"D.L. Becker","is_ca":false},{"name":"Megan Coombes","is_ca":false},{"name":"George Ioannidis","is_ca":true},{"name":"Jonathan D. Adachi","is_ca":true},{"name":"Ron Goeree","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05585751407707094,"gpt":0.3573413247138505,"spread":0.3014838106367796,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00307457,0.000636496,0.0008136809,0.001142119,0.0009256834,0.001711189,0.001502072,0.0007606634,0.002705304],"category_scores_gemma":[0.009982486,0.0005254108,0.001872116,0.002105338,0.0006599479,0.0005872768,0.0009653967,0.001090392,0.00008993685],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07821641,"about_ca_system_score_gemma":0.07900496,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9854587,"about_ca_topic_score_gemma":0.9785913,"domain_scores_codex":[0.9978964,0.0008519471,0.00008453236,0.0001384227,0.0004964084,0.0005321684],"domain_scores_gemma":[0.9966,0.001550262,0.0003829064,0.00007936279,0.001068656,0.000318914],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.003983946,0.0002992011,0.09750312,0.001413046,0.003105165,0.0004549637,0.0002143531,0.8280095,0.0004716636,0.01595086,0.008841597,0.03975268],"study_design_scores_gemma":[0.003762742,0.0009624781,0.1333217,0.001099673,0.003922963,0.0002980782,0.0007837364,0.8304217,0.0009619921,0.007434288,0.01682225,0.0002084353],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9224259,0.01749389,0.006463485,0.007756585,0.0001274457,0.001472473,0.02195988,0.0001374366,0.02216294],"genre_scores_gemma":[0.9913421,0.002691674,0.00176446,0.000327801,0.00001596821,0.0001189218,0.002212734,0.00001306471,0.001513228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07821641,"threshold_uncertainty_score":0.5675024,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2337280501","doi":"10.3111/13696998.2016.1164174","title":"The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"Biogen","keywords":"Dimethyl fumarate; Relapsing remitting; Medicine; Multiple sclerosis; Cost effectiveness; Internal medicine; Oncology; Immunology","authors":[{"name":"Wenqing Su","is_ca":false},{"name":"Colin Vicente","is_ca":false},{"name":"Baris Deniz","is_ca":false},{"name":"Sujata P. Sarda","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08091913144112999,"gpt":0.3192051370431769,"spread":0.2382860056020469,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001911428,0.0008661441,0.0009901442,0.001072822,0.001138002,0.001884322,0.001818609,0.000965749,0.0043851],"category_scores_gemma":[0.006560541,0.0005284469,0.00179804,0.001178524,0.0006908127,0.0006390894,0.001002044,0.001278743,0.0001522579],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.08108833,"about_ca_system_score_gemma":0.08000493,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9778833,"about_ca_topic_score_gemma":0.9649132,"domain_scores_codex":[0.9990939,0.0003120351,0.00003447294,0.00008757271,0.0001978213,0.0002742603],"domain_scores_gemma":[0.9979491,0.0009037863,0.0001732334,0.00004134118,0.0005712484,0.0003613699],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.005887842,0.0003696525,0.03016479,0.0009526219,0.001013055,0.0004370064,0.0001333855,0.9028155,0.0006290303,0.009841871,0.007477019,0.04027825],"study_design_scores_gemma":[0.003408889,0.0009781567,0.02715392,0.0004963973,0.001494755,0.000206263,0.0004276081,0.9540896,0.0007942239,0.004033698,0.00678918,0.0001272541],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9208884,0.01386231,0.008023104,0.008282104,0.0001785265,0.001333215,0.01924207,0.0002306344,0.02795968],"genre_scores_gemma":[0.9923746,0.002025389,0.001948823,0.000216121,0.000009156434,0.00009884792,0.001654512,0.00001396541,0.001658745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08108833,"threshold_uncertainty_score":0.5883398,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1967232800","doi":"10.3111/13696998.2010.535577","title":"Changing costs and the impact on RSV prophylaxis","year":2010,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Respiratory viral infections research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster Children's Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; University of Toronto","funders":"","keywords":"Medicine; Intensive care medicine; Pre-exposure prophylaxis; Virology; Human immunodeficiency virus (HIV)","authors":[{"name":"Kelly Smart","is_ca":true},{"name":"Bosco Paes","is_ca":true},{"name":"Krista L. Lanctôt","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02339701712570027,"gpt":0.3641934151618424,"spread":0.3407963980361421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020633,0.0005513623,0.0005098996,0.0014999,0.0006438473,0.002719421,0.0008761499,0.0006770003,0.003128008],"category_scores_gemma":[0.01772837,0.0002430611,0.001638439,0.002384527,0.0005417123,0.0008879377,0.0007635964,0.001302188,0.0001836665],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.05325937,"about_ca_system_score_gemma":0.04500928,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.9240474,"about_ca_topic_score_gemma":0.91954,"domain_scores_codex":[0.9966898,0.0008309173,0.0001458911,0.00016882,0.001408107,0.000756429],"domain_scores_gemma":[0.9942428,0.001818301,0.0009736426,0.0001080301,0.002423811,0.0004332882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002367995,0.0002149986,0.6051467,0.002026257,0.003369465,0.001024446,0.0003635689,0.2175243,0.0006977897,0.01726606,0.01994086,0.1300575],"study_design_scores_gemma":[0.0003175488,0.0005344767,0.8667133,0.001905426,0.00222363,0.0008731458,0.001501972,0.08541096,0.001262785,0.005592784,0.03351491,0.0001490046],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8495361,0.03873868,0.00437854,0.02727265,0.00035643,0.0003755617,0.02767884,0.0001219253,0.05154131],"genre_scores_gemma":[0.9862846,0.006261345,0.001420452,0.0007834841,0.00004905593,0.00004588967,0.003191373,0.00002092851,0.00194291],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9240474,"threshold_uncertainty_score":0.3864256,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2108384961","doi":"10.3111/13696998.2011.629015","title":"Savings from the use of a probiotic formula in the prophylaxis of antibiotic-associated diarrhea","year":2011,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Microsoft","keywords":"Medicine; Probiotic; Lactobacillus casei; Placebo; Diarrhea; Lactobacillus acidophilus; Context (archaeology); Antibiotic-associated diarrhea; Incidence (geometry); Antibiotics; Internal medicine; Clostridium difficile; Microbiology; Food science; Biology; Fermentation; Alternative medicine","authors":[{"name":"Alvine Adrienne Kamdeu Fansi","is_ca":true},{"name":"Jason R. Guertin","is_ca":true},{"name":"Jacques LeLorier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.09765356787881542,"gpt":0.2869604975716361,"spread":0.1893069296928206,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003890657,0.000828168,0.001103901,0.0009596957,0.0001777438,0.001090024,0.0005843028,0.001023408,0.00227758],"category_scores_gemma":[0.01310869,0.0003771887,0.002986666,0.000959043,0.0004151851,0.001072475,0.0008581276,0.001353648,0.0001020925],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002424923,"about_ca_system_score_gemma":0.002397834,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002684143,"about_ca_topic_score_gemma":0.002855987,"domain_scores_codex":[0.9959092,0.003048849,0.0001849285,0.0001659735,0.0005184336,0.0001725917],"domain_scores_gemma":[0.9963177,0.002561064,0.0007297394,0.00009592518,0.0001492225,0.0001463008],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2091882,0.005652223,0.07522593,0.01034539,0.02095485,0.0008627689,0.0002597702,0.2201522,0.006570063,0.01094144,0.003323287,0.4365239],"study_design_scores_gemma":[0.07465471,0.1736921,0.2556739,0.008606891,0.06524719,0.002557429,0.001209769,0.348812,0.01747055,0.02171709,0.0297735,0.000585061],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9631568,0.02232622,0.004807943,0.00265095,0.0002436896,0.00103143,0.001245083,0.00006833008,0.004469647],"genre_scores_gemma":[0.9943178,0.002681601,0.002177729,0.0001788228,0.00002175043,0.0001565456,0.0001939854,0.00000345842,0.0002683793],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003890657,"threshold_uncertainty_score":0.02057606,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2919228285","doi":"10.1080/13696998.2019.1590842","title":"Cost-effectiveness of second-line atezolizumab in Canada for advanced non-small cell lung cancer (NSCLC)","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University; Western University; University of Alberta; William Osler Health System; Roche (Canada)","funders":"","keywords":"Atezolizumab; Docetaxel; Medicine; Nivolumab; Oncology; Lung cancer; Cost effectiveness; Clinical trial; Internal medicine; Chemotherapy; Cancer; Immunotherapy; Risk analysis (engineering)","authors":[{"name":"Umang Ondhia","is_ca":true},{"name":"Henry Jacob Conter","is_ca":true},{"name":"Scott Owen","is_ca":true},{"name":"Anna Zhou","is_ca":false},{"name":"Julian Nam","is_ca":true},{"name":"Sumeet Singh","is_ca":false},{"name":"Ahmed Abdulla","is_ca":false},{"name":"Paula Chu","is_ca":false},{"name":"Federico Felizzi","is_ca":false},{"name":"Noman Paracha","is_ca":false},{"name":"Randeep Sangha","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01627561786555592,"gpt":0.2918249683696434,"spread":0.2755493505040875,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002177313,0.001072636,0.001148811,0.001062947,0.0008562522,0.002067655,0.001531891,0.001094838,0.003429803],"category_scores_gemma":[0.01093547,0.0005029028,0.002565692,0.001328229,0.0006836337,0.0008252933,0.0008997036,0.001595056,0.0001245937],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07832159,"about_ca_system_score_gemma":0.07159378,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9517595,"about_ca_topic_score_gemma":0.9442334,"domain_scores_codex":[0.998714,0.0004669532,0.00005652142,0.0001424403,0.0003085466,0.0003114593],"domain_scores_gemma":[0.9973645,0.001076278,0.0003560601,0.0000552258,0.0007470879,0.0004007985],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","study_design_scores_codex":[0.01565409,0.0008751741,0.06323203,0.003547428,0.005406884,0.0006344479,0.0002058286,0.7645606,0.001096262,0.01379303,0.01471277,0.1162815],"study_design_scores_gemma":[0.008114524,0.003958237,0.1034946,0.002090672,0.01104419,0.0008393644,0.0008832753,0.8355688,0.002189635,0.009417695,0.02207609,0.0003229605],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.899478,0.04172386,0.007631793,0.01061679,0.000349918,0.001487835,0.02050716,0.0001788578,0.0180259],"genre_scores_gemma":[0.9908423,0.003418709,0.00184532,0.0003638677,0.00002032497,0.0001137386,0.002082325,0.00001572456,0.001297681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9216784,"threshold_uncertainty_score":0.5682656,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4402836199","doi":"10.1080/13696998.2024.2407631","title":"Epidemiology and burden of chronic insomnia disorder in Europe: an analysis of the 2020 National Health and Wellness Survey","year":2024,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Sleep and related disorders","field":"Psychology","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Epidemiology; Insomnia; Chronic insomnia; Psychiatry; Environmental health; Gerontology; Family medicine; Internal medicine; Sleep disorder","authors":[{"name":"François-Xavier Chalet","is_ca":false},{"name":"Emiliano Albanese","is_ca":false},{"name":"Carlos Egea","is_ca":false},{"name":"Jason Ellis","is_ca":false},{"name":"Luigi Ferini‐Strambi","is_ca":false},{"name":"Anna Heidbreder","is_ca":false},{"name":"Damien Léger","is_ca":false},{"name":"Kushal Modi","is_ca":false},{"name":"Charles M. Morin","is_ca":true},{"name":"Abisola Olopoenia","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02693850627665624,"gpt":0.3539406247598802,"spread":0.327002118483224,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002045542,0.0003102071,0.0004098381,0.00152604,0.0002050798,0.0006914736,0.0004150694,0.0003942887,0.000538059],"category_scores_gemma":[0.001826557,0.0001918403,0.001103124,0.002423539,0.0001717826,0.0003672193,0.000723213,0.0002584274,0.0001570009],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007248251,"about_ca_system_score_gemma":0.000666025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.04304975,"about_ca_topic_score_gemma":0.02192387,"domain_scores_codex":[0.9992626,0.0002152382,0.000141472,0.0001614591,0.0001271715,0.00009195178],"domain_scores_gemma":[0.9987368,0.0001223988,0.00064551,0.00007424698,0.0002512007,0.0001698228],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004071134,0.000008683607,0.9982755,0.0000248286,0.0001186435,0.00001682762,0.00002566961,0.00009046334,0.00002607919,0.00002030786,0.000481468,0.0008707424],"study_design_scores_gemma":[0.0000036695,0.0000112413,0.9994492,0.00001132159,0.00002001275,0.00002778529,0.00004723022,0.0001256006,0.000007289277,0.000009168805,0.0002859429,0.000001560207],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9736574,0.003355365,0.0003477741,0.0002695599,0.00003731063,0.00003478555,0.02126923,0.0000243585,0.00100422],"genre_scores_gemma":[0.9795958,0.001112343,0.0003237236,0.0001852907,0.0000336094,0.00005283026,0.01847529,0.000005811419,0.0002153612],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04304975,"threshold_uncertainty_score":0.08559835,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2171964208","doi":"10.3111/13696998.2012.667028","title":"Tumor necrosis factor blocker dose escalation among biologic naïve rheumatoid arthritis patients in commercial managed-care plans in the 2 years following therapy initiation","year":2012,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Thomson Reuters (Canada)","funders":"","keywords":"Medicine; Etanercept; Adalimumab; Infliximab; Rheumatoid arthritis; Internal medicine; Tumor necrosis factor alpha; Surgery","authors":[{"name":"Machaon Bonafede","is_ca":true},{"name":"Shravanthi R. Gandra","is_ca":false},{"name":"Kathleen M. Fox","is_ca":false},{"name":"Kathleen Wilson","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0204339455573577,"gpt":0.2750843191235194,"spread":0.2546503735661617,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002776897,0.0002266117,0.0003293479,0.0009840524,0.0002522036,0.0009712309,0.0004241257,0.0005041132,0.0006489695],"category_scores_gemma":[0.01177802,0.0002064038,0.000692289,0.001173254,0.0002130222,0.0007403807,0.0005090854,0.0005992525,0.0001327871],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001142039,"about_ca_system_score_gemma":0.0005584155,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006630812,"about_ca_topic_score_gemma":0.006521377,"domain_scores_codex":[0.9971403,0.001184662,0.0003896459,0.0004940975,0.0005801617,0.000211155],"domain_scores_gemma":[0.9840259,0.002945536,0.01165685,0.000394675,0.0005042492,0.0004728245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001637657,0.00002905256,0.9982863,0.000004578861,0.00004795812,0.00003425109,0.00004411003,0.0001417536,0.00004988482,0.000009958077,0.00004114766,0.001147223],"study_design_scores_gemma":[0.00002820102,0.0002465832,0.9968197,0.000009842497,0.00005440997,0.0003074557,0.0001106139,0.002067873,0.0001426068,0.00002080095,0.0001865217,0.000005374523],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999199,0.0002255686,0.0001149139,0.00004150027,0.000001991969,0.00001009329,0.0002280422,0.000004620953,0.0001743049],"genre_scores_gemma":[0.9993623,0.00005401782,0.0001459476,0.00002293022,0.000008155976,0.000007899029,0.0003621354,9.337162e-7,0.00003574093],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006630812,"threshold_uncertainty_score":0.01468575,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2910482049","doi":"10.1080/13696998.2019.1569446","title":"Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma","year":2019,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Metastatic melanoma; Cohort; Oncology; Internal medicine; Melanoma; Overall survival; Cancer","authors":[{"name":"Edward Gibson","is_ca":false},{"name":"Najida Begum","is_ca":false},{"name":"Ian Koblbauer","is_ca":false},{"name":"George Dranitsaris","is_ca":true},{"name":"Danny Liew","is_ca":false},{"name":"Phil McEwan","is_ca":false},{"name":"Yong Yuan","is_ca":false},{"name":"A. Juarez-Garcia","is_ca":false},{"name":"David Tyas","is_ca":false},{"name":"Clive Pritchard","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1416524573366851,"gpt":0.4049893729289035,"spread":0.2633369155922184,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0123825,0.000816907,0.0009932185,0.0008743111,0.0004194063,0.001324255,0.001209766,0.001390635,0.004716957],"category_scores_gemma":[0.02937031,0.0006620829,0.001766745,0.0008245175,0.0006429171,0.001266177,0.001255241,0.002071858,0.0002118615],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003267266,"about_ca_system_score_gemma":0.002839268,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01858597,"about_ca_topic_score_gemma":0.01392525,"domain_scores_codex":[0.9963731,0.003093024,0.00007450144,0.0001631319,0.0001617413,0.0001344167],"domain_scores_gemma":[0.9614375,0.03568821,0.001194843,0.0004001369,0.0008311002,0.0004482218],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0002958904,0.00003585722,0.001472827,0.00004441923,0.00007134169,0.00002645469,0.00002497134,0.9886346,0.00005043175,0.007009115,0.000207626,0.002126597],"study_design_scores_gemma":[0.00005613377,0.0001051113,0.0002808833,0.00002680957,0.00002722447,0.000007033171,0.00001297,0.9943864,0.00005709294,0.004742606,0.0002900699,0.000007689237],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5239168,0.002087336,0.448279,0.00443601,0.0002577279,0.001122903,0.002440697,0.0003654441,0.01709402],"genre_scores_gemma":[0.9595191,0.0005892847,0.03663727,0.0002891015,0.00004553033,0.0006604017,0.0005142649,0.00003910616,0.001705887],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01858597,"threshold_uncertainty_score":0.06548572,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4360989335","doi":"10.1080/13696998.2023.2195753","title":"A systematic review of SF-6D health state valuation studies","year":2023,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"Fonds de Recherche du Québec - Santé","keywords":"Checklist; Medicine; Valuation (finance); Preference; Dimension (graph theory); Health economics; Quality-adjusted life year; Population; Quality of life (healthcare); Scopus; EQ-5D; Systematic review; MEDLINE; Actuarial science; Health related quality of life; Statistics; Psychology; Public health; Environmental health; Cost effectiveness; Economics","authors":[{"name":"Liang Wang","is_ca":true},{"name":"Thomas G. Poder","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7462706308130562,"gpt":0.5826734476324421,"spread":0.1635971831806141,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01559219,0.002247092,0.008618921,0.02799687,0.00100382,0.003159805,0.002394823,0.002139285,0.006707868],"category_scores_gemma":[0.07658693,0.001041746,0.009884049,0.02373254,0.001244179,0.002926719,0.00222226,0.001263018,0.0005083581],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006218493,"about_ca_system_score_gemma":0.01706115,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.007907875,"about_ca_topic_score_gemma":0.01728949,"domain_scores_codex":[0.9815525,0.005953746,0.007830911,0.001140781,0.003131107,0.0003909978],"domain_scores_gemma":[0.947479,0.03839445,0.00846404,0.0008224846,0.004488952,0.0003512098],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0001227924,0.00001173224,0.0006713498,0.9559965,0.004521594,0.00009918326,0.000202342,0.0001122722,0.0000977447,0.0003655223,0.001394791,0.03640422],"study_design_scores_gemma":[0.0001266856,0.0001209325,0.002905942,0.9495535,0.02860323,0.0002820442,0.0002746728,0.00007079256,0.0001159174,0.0004381999,0.01747327,0.00003485771],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00156776,0.9938445,0.0005765239,0.0004149603,0.0001522626,0.0009306195,0.001769547,0.00001721287,0.0007265631],"genre_scores_gemma":[0.01694345,0.9773349,0.001777162,0.00061393,0.00009717045,0.002153369,0.00091626,0.00001056601,0.0001531764],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02799687,"threshold_uncertainty_score":0.08246034,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2252889185","doi":"10.3111/13696998.2015.1100115","title":"Pharmacoeconomics of long-acting atypical antipsychotics for acutely relapsed chronic schizophrenia in Finland","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Risperidone; Aripiprazole; Tolerability; Paliperidone; Olanzapine; Internal medicine; Schizophrenia (object-oriented programming); Adverse effect; Psychiatry","authors":[{"name":"Thomas R. Einarson","is_ca":true},{"name":"Hanna Pudas","is_ca":false},{"name":"Pushpendra Goswami","is_ca":false},{"name":"K. Van Impe","is_ca":false},{"name":"Basil G. Bereza","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05978874739694853,"gpt":0.3764482381906464,"spread":0.3166594907936979,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00542124,0.0004106099,0.0007862029,0.0008877728,0.0003031502,0.001111598,0.0004372227,0.0007491183,0.001558126],"category_scores_gemma":[0.01456787,0.0002741108,0.002709083,0.0008875373,0.0002343875,0.0005014237,0.0006220571,0.0005760459,0.00005484815],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004736555,"about_ca_system_score_gemma":0.003111066,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02357126,"about_ca_topic_score_gemma":0.01302849,"domain_scores_codex":[0.9973832,0.001765313,0.0001662085,0.0001814056,0.0003073249,0.0001965823],"domain_scores_gemma":[0.9894723,0.00824395,0.001712473,0.0001177367,0.0002498888,0.0002035399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008211907,0.0005777425,0.5547925,0.001698815,0.01026433,0.00245091,0.0003666148,0.3874968,0.001311209,0.00282448,0.001950793,0.028054],"study_design_scores_gemma":[0.001542792,0.002280004,0.7475911,0.001256009,0.006617396,0.00159884,0.0008416465,0.2254931,0.001160387,0.008348619,0.00309318,0.0001769127],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9887564,0.005558969,0.0007161368,0.001051358,0.00001538018,0.00008126844,0.002953012,0.000009012808,0.0008585029],"genre_scores_gemma":[0.9978217,0.0008259157,0.0002774755,0.000111877,0.00001033091,0.00003531098,0.0008254937,0.000002600046,0.00008920494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02357126,"threshold_uncertainty_score":0.04686809,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168221836","doi":"10.3111/13696998.2013.779277","title":"Medical resource use and costs associated with chylomicronemia","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Acute pancreatitis; Hypertriglyceridemia; Pancreatitis; Internal medicine; Medical costs; Demographics; Gastroenterology; Pediatrics; Triglyceride; Cholesterol; Demography; Health care","authors":[{"name":"Daniel Gaudet","is_ca":true},{"name":"James Signorovitch","is_ca":false},{"name":"Elyse Swallow","is_ca":false},{"name":"Liangyi Fan","is_ca":false},{"name":"Karine Tremblay","is_ca":true},{"name":"Diane Brisson","is_ca":true},{"name":"Charles D. Meyers","is_ca":false},{"name":"Jean-Bernard Gruenberger","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01033664638922221,"gpt":0.2274725491197174,"spread":0.2171359027304952,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004586671,0.0002194251,0.000232853,0.001499199,0.0002815851,0.0007482116,0.0003704177,0.0003806442,0.001982902],"category_scores_gemma":[0.004711589,0.0001854284,0.0006194557,0.002390905,0.0001906729,0.0004364186,0.0006820777,0.0005481468,0.0001392522],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001357577,"about_ca_system_score_gemma":0.0005903474,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01520385,"about_ca_topic_score_gemma":0.01379607,"domain_scores_codex":[0.9989474,0.0003237682,0.0002028152,0.00009884774,0.0002262039,0.0002008749],"domain_scores_gemma":[0.9972357,0.0004409381,0.001734078,0.00005689847,0.0001960974,0.0003362677],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0001043406,0.00005295681,0.9961367,0.0000312444,0.0001229927,0.0001481027,0.00002967125,0.0004566584,0.00004687992,0.00007595601,0.0003375061,0.002457018],"study_design_scores_gemma":[0.000005849694,0.00003332596,0.9979716,0.00002900799,0.00003414836,0.0003420288,0.00009846286,0.001172493,0.00002768815,0.00005564764,0.0002247938,0.000004878559],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956504,0.0009687189,0.00007100664,0.0003187192,0.00001042813,0.00001875899,0.001984793,0.000003986316,0.000973106],"genre_scores_gemma":[0.998425,0.0002912294,0.00007004646,0.00003258181,0.00001428508,0.00001090117,0.001074413,9.440147e-7,0.00008063367],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01520385,"threshold_uncertainty_score":0.0302307,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2740431138","doi":"10.1080/13696998.2017.1363050","title":"Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands","year":2017,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Paliperidone Palmitate; Paliperidone; Risperidone; Cost effectiveness; Olanzapine; Quality-adjusted life year; Emergency medicine; Schizophrenia (object-oriented programming); Psychiatry","authors":[{"name":"Thomas R. Einarson","is_ca":true},{"name":"Basil G. Bereza","is_ca":true},{"name":"Fadi Tedouri","is_ca":false},{"name":"K. Van Impe","is_ca":false},{"name":"Tom Denee","is_ca":false},{"name":"Pieter J. T. Dries","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0715635955191591,"gpt":0.3826967046580764,"spread":0.3111331091389173,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004031438,0.0007220914,0.001029363,0.0007204002,0.0001891467,0.00158152,0.00107239,0.0008286629,0.003743469],"category_scores_gemma":[0.01642161,0.0005731469,0.002719786,0.0009816576,0.0002991827,0.001236766,0.0007571728,0.0008860734,0.0001842443],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008753928,"about_ca_system_score_gemma":0.004606125,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0884488,"about_ca_topic_score_gemma":0.04051896,"domain_scores_codex":[0.9970297,0.002209574,0.0001276706,0.0001823904,0.000218334,0.0002323871],"domain_scores_gemma":[0.9952353,0.00367022,0.0005725822,0.00006743519,0.0002421226,0.0002123693],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.004125346,0.0003367921,0.01321441,0.0009569022,0.001632626,0.0004478209,0.00009588475,0.9492009,0.0002636857,0.003863255,0.002304859,0.02355757],"study_design_scores_gemma":[0.003620077,0.002145255,0.03017322,0.0007186357,0.002185198,0.0003856607,0.0004985745,0.9468915,0.0005754768,0.007804352,0.004880026,0.0001220633],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9583313,0.00797273,0.007115022,0.002432725,0.0001534117,0.0009445652,0.01046541,0.00005576728,0.01252893],"genre_scores_gemma":[0.9937692,0.001161557,0.001847499,0.0001554707,0.00001448687,0.0003535708,0.001517783,0.00002001675,0.001160356],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0884488,"threshold_uncertainty_score":0.1758679,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2292517844","doi":"10.3111/13696998.2015.1106546","title":"Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in Canada","year":2015,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Hepatitis C virus research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McMaster University","funders":"","keywords":"Sofosbuvir; Medicine; Daclatasvir; Internal medicine; Regimen; Ribavirin; Quality-adjusted life year; Cost effectiveness; Hepatitis C; Hepatitis C virus; Gastroenterology; Virology; Virus","authors":[{"name":"Andriy Moshyk","is_ca":false},{"name":"Myriam Martel","is_ca":false},{"name":"Amir Abbas Tahami Monfared","is_ca":false},{"name":"Ron Goeree","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.103942481667577,"gpt":0.3671978009279744,"spread":0.2632553192603975,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00178442,0.0006316403,0.0007451189,0.0008324598,0.001106324,0.001128145,0.001175553,0.0005790013,0.002256758],"category_scores_gemma":[0.005504631,0.0004039955,0.00132977,0.001071621,0.0005755723,0.0003945057,0.0007657742,0.0007360879,0.00006135664],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07278676,"about_ca_system_score_gemma":0.05841462,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9736986,"about_ca_topic_score_gemma":0.9691852,"domain_scores_codex":[0.9988342,0.0004425953,0.00004272716,0.0000888123,0.0002579748,0.0003336751],"domain_scores_gemma":[0.9981866,0.0007355236,0.0002305981,0.00003347663,0.0004609009,0.0003528546],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.009609959,0.0009955546,0.1047305,0.0009138595,0.001584359,0.0006367461,0.0002689543,0.8078677,0.001515278,0.007800282,0.005087891,0.05898894],"study_design_scores_gemma":[0.00271223,0.001689239,0.09448418,0.0002471897,0.001248948,0.0002455567,0.0004991761,0.8928624,0.0008343033,0.002011457,0.003040014,0.0001252214],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.982794,0.003474452,0.002257067,0.00183502,0.00003819665,0.0005129278,0.002974027,0.00004875931,0.006065463],"genre_scores_gemma":[0.9968663,0.0007317274,0.001146706,0.00009725198,0.000005244588,0.00004717249,0.0005287796,0.000004401472,0.0005723797],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07278676,"threshold_uncertainty_score":0.5281073,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2059760712","doi":"10.3111/13696998.2015.1033423","title":"Costing bias in economic evaluations","year":2015,"lang":"en","type":"editorial","venue":"Journal of Medical Economics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université de Montréal; Université du Québec à Montréal","funders":"","keywords":"Activity-based costing; Health care; Risk analysis (engineering); Health economics; Process (computing); Key (lock); Psychological intervention; Target costing; Medicine; Operations management; Actuarial science; Computer science; Business; Economics; Nursing; Accounting; Computer security","authors":[{"name":"Gabriel Tremblay","is_ca":false},{"name":"Mark Charny","is_ca":false},{"name":"L. Martin Cloutier","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.4713449133992674,"gpt":0.5149067998982277,"spread":0.04356188649896031,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1241038,0.002594058,0.004863806,0.005457331,0.002617345,0.01197353,0.005321601,0.01824264,0.007167134],"category_scores_gemma":[0.5291955,0.001288931,0.004716925,0.00437756,0.00965721,0.008361502,0.003212843,0.02272877,0.002587599],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006039084,"about_ca_system_score_gemma":0.006861974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001149257,"about_ca_topic_score_gemma":0.001876709,"domain_scores_codex":[0.8321748,0.09658062,0.02728395,0.004879708,0.03806223,0.001018744],"domain_scores_gemma":[0.3722949,0.5503001,0.01630491,0.008633215,0.05073326,0.001733581],"domain_codex":null,"domain_gemma":"methods","domain_candidate":"methods","domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001523414,0.00002389968,0.0002310371,0.006201542,0.0006026933,0.0002052728,0.0002687514,0.000325961,0.00006455062,0.02624386,0.8744927,0.0911874],"study_design_scores_gemma":[0.0003673797,0.00008341834,0.0007905,0.02082932,0.0009144862,0.0006417264,0.0002040006,0.001610734,0.0003579704,0.1102002,0.8638491,0.000151235],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.0002587834,0.1478832,0.007070926,0.1860226,0.6525021,0.0001826549,0.0001527874,0.0001432368,0.005783737],"genre_scores_gemma":[0.006536154,0.07291145,0.007110874,0.08765443,0.8212346,0.0003326767,0.0000836956,0.000226934,0.003909148],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.8758962,"threshold_uncertainty_score":0.6563313,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050660689","doi":"10.3111/13696998.2014.903256","title":"Is transcatheter aortic valve implantation (TAVI) a cost-effective treatment in patients who are ineligible for surgical aortic valve replacement? A systematic review of economic evaluations","year":2014,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Reimbursement; Economic evaluation; Purchasing power parity; MEDLINE; Health technology; Meta-analysis; Aortic valve replacement; Health care; Checklist; Cost effectiveness; Actuarial science; Finance; Stenosis; Internal medicine; Economics; Exchange rate","authors":[{"name":"James Eaton","is_ca":false},{"name":"Stuart Mealing","is_ca":false},{"name":"Juliette C. Thompson","is_ca":false},{"name":"Neil Moat","is_ca":false},{"name":"A. Pieter Kappetein","is_ca":false},{"name":"Nicolò Piazza","is_ca":true},{"name":"Rachele Busca","is_ca":false},{"name":"Ruben L.J. Osnabrugge","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0349624507930824,"gpt":0.4217727569544759,"spread":0.3868103061613935,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02916646,0.001318004,0.0115427,0.01393242,0.0006322517,0.004558435,0.00141226,0.002564275,0.00247081],"category_scores_gemma":[0.1487596,0.001217473,0.012447,0.01085979,0.001271577,0.003136001,0.001217958,0.001785091,0.0001585409],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006703603,"about_ca_system_score_gemma":0.01167168,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005741254,"about_ca_topic_score_gemma":0.01328938,"domain_scores_codex":[0.9651932,0.01648756,0.01206288,0.001361332,0.004484977,0.0004101169],"domain_scores_gemma":[0.8479795,0.1241538,0.01956844,0.001349752,0.006297304,0.0006512248],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0008210405,0.00003334404,0.001931871,0.9119812,0.03775461,0.0001172681,0.0001412283,0.0003585251,0.0001346501,0.0004865191,0.001053486,0.04518627],"study_design_scores_gemma":[0.001027636,0.0006422718,0.008060297,0.7792233,0.1985097,0.0004418707,0.0003452197,0.0006412091,0.0002873589,0.001021183,0.009726918,0.00007300882],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002865494,0.9948739,0.0003414303,0.0006394588,0.0001553071,0.0003707734,0.0004142336,0.000007818283,0.0003315696],"genre_scores_gemma":[0.06682316,0.9284146,0.001918035,0.0009235975,0.000186005,0.001250054,0.000367174,0.00001098474,0.0001064705],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02916646,"threshold_uncertainty_score":0.1542488,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1992802587","doi":"10.3111/13696998.2014.897626","title":"Economic evaluation of BST-CarGel as an adjunct to microfracture vs microfracture alone in knee cartilage surgery","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Medicine; Knee replacement; Surgery; Orthopedic surgery; Referral; Cartilage damage; Osteoarthritis; Articular cartilage","authors":[{"name":"William D. Stanish","is_ca":true},{"name":"Mats Brittberg","is_ca":false},{"name":"Matthias Steinwachs","is_ca":false},{"name":"Lydia Crowe","is_ca":false},{"name":"D.J.S. Castelo","is_ca":false},{"name":"Alberto Restrepo","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01677445460773767,"gpt":0.2904359798159504,"spread":0.2736615252082127,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009681306,0.001125618,0.001646938,0.001192119,0.0002684805,0.001779132,0.0008754656,0.001599898,0.003889557],"category_scores_gemma":[0.01507746,0.0005458739,0.002958423,0.0008177531,0.0006567859,0.001333727,0.0007993961,0.001427936,0.0001468328],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.005584388,"about_ca_system_score_gemma":0.003451037,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004691409,"about_ca_topic_score_gemma":0.002629996,"domain_scores_codex":[0.9956161,0.003438628,0.0001156833,0.0001902441,0.0003218236,0.0003175069],"domain_scores_gemma":[0.9864541,0.01194683,0.0006897765,0.0001102095,0.0003389676,0.000460078],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.01932961,0.001115845,0.00984908,0.001357783,0.00152101,0.0002670366,0.00006779721,0.9369231,0.0008289574,0.004571123,0.0004795572,0.02368909],"study_design_scores_gemma":[0.002274092,0.01638154,0.01029937,0.0004802058,0.003283889,0.00020353,0.0002852428,0.9595311,0.001215083,0.004590357,0.001367936,0.00008772913],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.973731,0.005472955,0.01188949,0.001315233,0.00009549918,0.001168436,0.001020927,0.00002830534,0.005278117],"genre_scores_gemma":[0.996911,0.000590147,0.001788095,0.00006645976,0.00001071051,0.0001619503,0.0001808306,0.000002912501,0.000287896],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009681306,"threshold_uncertainty_score":0.05120021,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1979583846","doi":"10.3111/13696998.2014.950669","title":"Healthcare costs for Crohn’s disease patients treated with infliximab: a propensity weighted comparison of the effects of treatment adherence","year":2014,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Robarts Clinical Trials; Western University","funders":"","keywords":"Medicine; Infliximab; Propensity score matching; Internal medicine; Pharmacy; Rheumatoid arthritis; Crohn's disease; Surgery; Disease; Family medicine","authors":[{"name":"Brian G. Feagan","is_ca":true},{"name":"Chris M Kozma","is_ca":false},{"name":"Terra Slaton","is_ca":false},{"name":"William H. Olson","is_ca":false},{"name":"George J. Wan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.00986530010196417,"gpt":0.2562391222970435,"spread":0.2463738221950793,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003638427,0.0003939902,0.0008855226,0.0009199625,0.0002816348,0.0009565076,0.0004316387,0.0006823585,0.001383355],"category_scores_gemma":[0.01139556,0.0003214329,0.00277085,0.001111963,0.0003142411,0.0008157697,0.0007853471,0.0007467268,0.0001338732],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005128696,"about_ca_system_score_gemma":0.000283675,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001622907,"about_ca_topic_score_gemma":0.001217333,"domain_scores_codex":[0.9967701,0.001826406,0.0004124839,0.000399235,0.0003942894,0.00019758],"domain_scores_gemma":[0.9953207,0.001652155,0.00213521,0.0004147098,0.0001950422,0.0002820851],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02062273,0.0007762137,0.9484192,0.0001458085,0.008918822,0.0001256736,0.0001971686,0.001867267,0.0004312488,0.000441433,0.0003940089,0.01766045],"study_design_scores_gemma":[0.00101598,0.004034013,0.9854738,0.00004670117,0.002144835,0.0002957192,0.0002621796,0.005448394,0.0001739261,0.0004851953,0.0005848482,0.00003443167],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.998549,0.0004882965,0.0003259283,0.00006523846,0.00001265537,0.00003284691,0.0002326124,0.000002827378,0.0002905188],"genre_scores_gemma":[0.9991333,0.0001227789,0.0001653902,0.0000383261,0.00001295956,0.00002477012,0.0004099495,0.000001840382,0.00009069982],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003638427,"threshold_uncertainty_score":0.01924211,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2106512674","doi":"10.3111/13696990701438629","title":"Cost effectiveness of rimonabant use in patients at increased cardiometabolic risk: estimates from a Markov model","year":2007,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University","funders":"Johns Hopkins University; Sanofi","keywords":"Medicine; Rimonabant; Overweight; Quality-adjusted life year; Cost effectiveness; Obesity; Internal medicine; Risk analysis (engineering)","authors":[{"name":"J. Jaime","is_ca":true},{"name":"Ipek Özer Stillman","is_ca":false},{"name":"A Danel","is_ca":false},{"name":"Denis Getsios","is_ca":false},{"name":"P McEwan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01895269973768576,"gpt":0.2711988113097658,"spread":0.25224611157208,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007269708,0.001199992,0.001903947,0.001474495,0.0004746128,0.001729377,0.001315641,0.001393533,0.004714964],"category_scores_gemma":[0.01826881,0.0009335704,0.003032772,0.00104464,0.0007718049,0.001284392,0.00132508,0.001786314,0.0002992704],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003786772,"about_ca_system_score_gemma":0.002514759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01844442,"about_ca_topic_score_gemma":0.01004845,"domain_scores_codex":[0.9978513,0.001555498,0.00008079319,0.000138441,0.0001349007,0.0002392105],"domain_scores_gemma":[0.9753402,0.02245807,0.001103876,0.0003157487,0.000462744,0.0003192925],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.0006321144,0.00007254093,0.003661933,0.00009851829,0.0002433974,0.0001060262,0.00003857083,0.9865558,0.0001038926,0.005861387,0.0003947577,0.00223113],"study_design_scores_gemma":[0.0001489921,0.0002223764,0.00193952,0.00009131105,0.0002565881,0.00006188959,0.00004457281,0.9896016,0.00009586497,0.007184962,0.0003237304,0.00002861995],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8949742,0.003364735,0.07936264,0.002789876,0.00006676441,0.0006259051,0.004736314,0.000124174,0.01395539],"genre_scores_gemma":[0.9912646,0.0007829423,0.005016044,0.0001146231,0.00002156551,0.0002591779,0.0008424642,0.00001343436,0.001685192],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01844442,"threshold_uncertainty_score":0.03844637,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2097511134","doi":"10.3111/13696998.2013.857676","title":"Understanding the economic, daily functioning, and diabetes management burden of non-severe nocturnal hypoglycemic events in Canada: differences between type 1 and type 2","year":2013,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Diabetes Management and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Medicine; Type 2 diabetes; Nocturnal; Diabetes mellitus; Diabetes management; Type 1 diabetes; Pediatrics; Gerontology; Intensive care medicine; Internal medicine; Endocrinology","authors":[{"name":"Meryl Brod","is_ca":false},{"name":"Michael Lyng Wolden","is_ca":false},{"name":"Danielle Groleau","is_ca":false},{"name":"Donald M. Bushnell","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03986739751327643,"gpt":0.2527847276198688,"spread":0.2129173301065923,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007594331,0.0002656256,0.0003089327,0.001353293,0.001948412,0.001493748,0.0007738821,0.0003608684,0.002176068],"category_scores_gemma":[0.002974753,0.0002108766,0.0006225286,0.003392728,0.0004881686,0.0006126317,0.0008148926,0.0006545993,0.0001246493],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0222411,"about_ca_system_score_gemma":0.0240204,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9939733,"about_ca_topic_score_gemma":0.995611,"domain_scores_codex":[0.9991879,0.00004867613,0.00004388494,0.00006592662,0.0003336631,0.000320054],"domain_scores_gemma":[0.9984067,0.0001127085,0.0003833183,0.000022043,0.0006073255,0.000467813],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00004603116,0.00004060771,0.9891122,0.00006167038,0.00004520338,0.00007006741,0.0010161,0.000150681,0.00005797706,0.00009345738,0.0009471545,0.008358904],"study_design_scores_gemma":[0.000003492824,0.00001279905,0.99752,0.00004244204,0.0000138898,0.0000240647,0.001699763,0.0001671977,0.0000158962,0.00002101224,0.0004738567,0.000005497342],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9912556,0.001668502,0.00008210417,0.001219551,0.00001630514,0.00003156174,0.002456004,0.000004208641,0.003266142],"genre_scores_gemma":[0.9970913,0.00126331,0.0001169639,0.0001864708,0.000006643012,0.00001017644,0.0008527722,0.000001880347,0.0004705099],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0222411,"threshold_uncertainty_score":0.1613712,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4384664050","doi":"10.1080/13696998.2023.2237336","title":"Early access for innovative oncology medicines: a different story in each nation","year":2023,"lang":"en","type":"review","venue":"Journal of Medical Economics","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true},"ca_institutions":"ABB (Canada)","funders":"AbbVie Canada","keywords":"Medicine; Internal medicine; Oncology; Family medicine","authors":[{"name":"Tara Cowling","is_ca":false},{"name":"Ransi Nayakarathna","is_ca":false},{"name":"Allison Wills","is_ca":false},{"name":"Dipti Tankala","is_ca":true},{"name":"Nancy Paul Roc","is_ca":true},{"name":"Stéphane Barakat","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.7144830394150865,"gpt":0.5836889240515664,"spread":0.1307941153635201,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02093756,0.0003289632,0.0007951712,0.003361259,0.005050901,0.01519469,0.001393284,0.007483874,0.006734449],"category_scores_gemma":[0.07038432,0.0006513644,0.001639732,0.004990287,0.008292002,0.02847729,0.01006597,0.01344637,0.0006679192],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.008712958,"about_ca_system_score_gemma":0.01251365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01413848,"about_ca_topic_score_gemma":0.01123106,"domain_scores_codex":[0.9804971,0.01001342,0.002309992,0.001398939,0.00342066,0.002359892],"domain_scores_gemma":[0.924028,0.04510463,0.008448103,0.003910741,0.01012577,0.008382742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005216812,0.0002387727,0.05250183,0.004761389,0.0003497607,0.004136427,0.06125877,0.0006900817,0.0006088126,0.3446144,0.255696,0.2746221],"study_design_scores_gemma":[0.0000384985,0.0001635051,0.02304866,0.007294842,0.0001882525,0.0027495,0.05644839,0.0002981663,0.00059966,0.05605041,0.8528959,0.0002242256],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.03662968,0.04333975,0.002614575,0.8702229,0.003346431,0.0000615325,0.001171256,0.00008032839,0.04253361],"genre_scores_gemma":[0.5883566,0.1224832,0.007852444,0.2664852,0.003618418,0.0003282118,0.001792043,0.0003684734,0.008715457],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.02093756,"threshold_uncertainty_score":0.1107298,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}